{"study_id": 34409, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the synergistic effects of Resveratrol (RES) and carbon monoxide (CO) gas therapy in a mitochondrial-targeted nanoplatform for combined tumor therapy.", "results_summary": "The study found that RES, when combined with CO gas therapy in a nanoplatform, disrupted tumor cell metabolism by inhibiting ATPase, enhancing the therapeutic effect. In vitro results demonstrated a synergistic anticancer effect between RES and CO.", "population_specificity": "Tumor cells (in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:17.158617+00:00"}
{"study_id": 196710, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of resveratrol on hyperlipidemia and neurological problems in people living with HIV (PLHIV).", "results_summary": "Resveratrol administration did not significantly affect cholesterol or triglyceride levels, nor did it improve psychological parameters such as depression, anxiety, sleep quality, or quality of life in PLHIV. The study suggested that larger-scale or longer-term trials might be needed to observe potential effects.", "population_specificity": "People living with HIV (PLHIV) in Iran.", "effective_dosage": "Not specified", "study_duration": "One month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:22.998465+00:00"}
{"study_id": 34421, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop a Resveratrol-loaded adhesive eutectogel to improve its solubility, stability, and skin retention for treating psoriasis and evaluate its therapeutic effects compared to a commercially available ointment.", "results_summary": "The eutectogel significantly enhanced Resveratrol's solubility, stability, and sustained skin penetration, effectively alleviating psoriasis symptoms in mice, inhibiting keratinocyte proliferation, and regulating IL-23/IL-17 axis-related factors, outperforming calcipotriol ointment.", "population_specificity": "Imiquimod-induced psoriasis-like mice model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.686293+00:00"}
{"study_id": 34417, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the therapeutic potential of resveratrol combined with copper in deactivating cell-free chromatin particles (cfChPs) and mitigating their harmful effects.", "results_summary": "The study found that resveratrol, when combined with copper, generates reactive oxygen species (ROS) that deactivate cfChPs without damaging genomic DNA, potentially offering therapeutic benefits for various diseases. The approach leverages ROS to neutralize cfChPs, suggesting a novel mechanism for resveratrol's therapeutic effects.", "population_specificity": "Not specified (cell-free chromatin particles in a theoretical or experimental model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:24.328175+00:00"}
{"study_id": 34419, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the antioxidant effects and underlying molecular mechanisms of Resveratrol (RES) in bovine mammary epithelial cells (BMECs) challenged by non-esterified fatty acids (NEFAs).", "results_summary": "RES ameliorated NEFA-induced oxidative damage by upregulating antioxidant enzyme expression, reducing oxidative stress markers (MDA and ROS), and restoring mitochondrial function (MMP, ATP production, NAD+/NADH ratio). In vivo studies in mice also showed RES alleviated oxidative damage and mitochondrial dysfunction in mammary gland tissue.", "population_specificity": "Bovine mammary epithelial cells (BMECs) and a mouse model of oxidative damage induced by a high-fat diet (HFD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:24.397209+00:00"}
{"study_id": 196713, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects and safety of Resveratrol supplementation in older adults across various health conditions.", "results_summary": "Resveratrol improved exercise adaptation, muscle function, and cognitive function in some populations but showed no significant benefit for diabetes or peripheral artery disease. High doses increased some cardiovascular risk biomarkers, but no significant adverse events were reported.", "population_specificity": "Older adults, including healthy individuals, those with functional limitations, Alzheimer's disease, overweight individuals, diabetes, and peripheral artery disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:24.397989+00:00"}
{"study_id": 196712, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to systematically evaluate the effects of resveratrol supplementation on lipid profile parameters in humans through an umbrella meta-analysis.", "results_summary": "Resveratrol supplementation was effective in reducing serum triglyceride (TG) and total cholesterol (TC) based on standardized mean difference (SMD) analysis, but not high-density lipoprotein cholesterol (HDL-c) or low-density lipoprotein-cholesterol (LDL-c). However, the decreases were not clinically significant, suggesting resveratrol may only serve as an adjunctive therapy for dyslipidemia.", "population_specificity": "Humans (specific demographic not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:25.096357+00:00"}
{"study_id": 196711, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether resveratrol could reduce aortic growth rate in adult patients with Marfan syndrome (MFS).", "results_summary": "Resveratrol treatment for approximately 1.2 years showed a trend toward stabilizing aortic growth rates in MFS patients, with observed decreases in estimated growth rates at multiple aortic levels, though statistical significance was borderline (p=0.072). The study concluded that longer-term randomized trials are needed to confirm these effects.", "population_specificity": "Adults aged 18-50 years with Marfan syndrome (MFS), including those with prior aortic root replacement.", "effective_dosage": "Not specified", "study_duration": "1.2 \u00b1 0.3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:25.334715+00:00"}
{"study_id": 196714, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the overall effects of resveratrol on anthropometric indices (e.g., BMI, waist circumference) and inflammatory markers (e.g., CRP, TNF-\u03b1) through an umbrella meta-analysis.", "results_summary": "Resveratrol supplementation significantly reduced BMI, waist circumference, CRP, and TNF-\u03b1 levels but had no significant effect on body weight or IL-6 levels unless administered for \u226512 weeks or at \u2265500 mg/day.", "population_specificity": "4,088 participants across 81 randomized controlled trials (specific demographics not detailed in the abstract).", "effective_dosage": "Effective dosage noted as \u2265500 mg/day.", "study_duration": "Intervention duration \u226512 weeks showed significant effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:26.149281+00:00"}
{"study_id": 196715, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves endothelial function in patients with chronic kidney disease (CKD) and diabetes.", "results_summary": "Resveratrol supplementation significantly improved endothelial function, as measured by brachial artery flow-mediated dilation, compared to placebo. No changes were observed in eGFR, hemoglobin A1c, blood pressure, or nitroglycerin-mediated dilation, suggesting the effect was independent of traditional cardiovascular risk factors.", "population_specificity": "Adults aged 68\u00b17 years (84% men) with stage 3 CKD and diabetes.", "effective_dosage": "400 mg/day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:31.740994+00:00"}
{"study_id": 196719, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves renal health biomarkers by analyzing evidence from randomized controlled trials.", "results_summary": "The meta-analysis found that resveratrol significantly reduced blood urea nitrogen levels, suggesting a beneficial effect on renal health biomarkers. The pooled results were statistically significant but based on a limited number of studies (n=32).", "population_specificity": "Not specified (general population from randomized controlled trials)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.465651+00:00"}
{"study_id": 196716, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review resveratrol's molecular therapeutic targets and potential mechanisms in attenuating pulmonary fibrosis across various respiratory diseases.", "results_summary": "Resveratrol demonstrated broad biological activities, including antioxidant, anti-inflammatory, and antiapoptotic effects, suggesting efficacy in treating respiratory diseases like interstitial lung disease, infectious diseases, and lung cancer. The study also highlighted current issues and controversies regarding its use as a pharmaceutical or supplement.", "population_specificity": "Patients with pulmonary fibrosis and related respiratory diseases, including cancer, COVID-19, idiopathic interstitial pneumonia, and systemic disorders like rheumatoid arthritis and systemic sclerosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.489721+00:00"}
{"study_id": 196717, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of resveratrol, in combination with equol, on bone turnover biomarkers in postmenopausal women.", "results_summary": "The study found that resveratrol (25 mg) combined with equol (10 mg) significantly improved bone turnover biomarkers (DPD, osteocalcin, and BAP) after 12 months of treatment compared to placebo.", "population_specificity": "Sixty healthy postmenopausal women.", "effective_dosage": "25 mg resveratrol (combined with 10 mg equol) daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.823271+00:00"}
{"study_id": 196722, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves serum lipid profiles and other metabolic markers in a dose-response manner in individuals with dyslipidemia.", "results_summary": "The abstract does not provide specific results, but it indicates that the efficacy and dose-response relationship of resveratrol in clinical trials remains unclear.", "population_specificity": "Individuals with dyslipidemia (n=168).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:33.650359+00:00"}
{"study_id": 196721, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Resveratrol supplementation on cardiac remodeling in hypertensive patients.", "results_summary": "Resveratrol supplementation improved left atrial remodeling, left ventricular diastolic function, and reduced cardiac fibrosis biomarkers, but did not significantly affect left ventricular structure or arterial stiffness compared to controls. Serum levels of sirtuin3, superoxide dismutase, and klotho increased significantly in the Resveratrol group.", "population_specificity": "Hypertensive patients (n=80, divided into Resveratrol and control groups).", "effective_dosage": "400 mg/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:33.822625+00:00"}
{"study_id": 196718, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine the effect of a \u03b4-tocotrienol and resveratrol mixture (TRM) on miRNA expression in patients with Metabolic Syndrome (MetS).", "results_summary": "TRM supplementation significantly upregulated miRNA-130b-5p and miRNA-221-5p while downregulating miRNA-122-5p, with no significant effect on miRNA-15b-5p or miRNA-376b-5p. Participants with reverted MetS showed stronger miRNA modulation compared to non-reverted patients.", "population_specificity": "82 adult patients with Metabolic Syndrome.", "effective_dosage": "150 mg resveratrol (combined with 250 mg \u03b4-tocotrienol) twice daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:33.907834+00:00"}
{"study_id": 196720, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of resveratrol supplementation on clinical parameters and inflammatory markers in patients with chronic periodontitis.", "results_summary": "Resveratrol supplementation significantly improved plaque index (PI) compared to the placebo group, but no significant differences were observed in pocket depth (PD), clinical attachment loss (CAL), bleeding index (BI), or salivary levels of IL-8 and IL-1\u03b2. The study concluded that resveratrol was helpful as an anti-inflammatory supplement alongside non-surgical periodontal treatments.", "population_specificity": "40 chronic periodontitis patients", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:34.532072+00:00"}
{"study_id": 196723, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol supplementation affects nitric oxide (NO)-mediated vascular outcomes in hypertension.", "results_summary": "Nine of ten animal studies showed significant positive effects of resveratrol on NO outcomes, with concomitant decreases in blood pressure in most cases. Resveratrol supplementation appears promising for improving NO-mediated vascular function and blood pressure, though human studies are needed.", "population_specificity": "Animal models (species not specified) with hypertension.", "effective_dosage": "Not specified (human equivalency doses inconsistent among studies).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:40.060985+00:00"}
{"study_id": 196724, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the dose-response effects of resveratrol supplementation on blood lipid profiles, specifically total cholesterol, triglycerides, LDL-C, and HDL-C.", "results_summary": "Resveratrol significantly reduced total cholesterol, triglycerides, and LDL-C levels but did not affect HDL-C. The reduction in LDL-C was more pronounced in trials lasting \u226512 weeks and in subjects with type 2 diabetes.", "population_specificity": "Subjects included in randomized controlled trials, with specific mention of type 2 diabetes mellitus patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Trials with durations of \u226512 weeks showed more significant effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:41.028921+00:00"}
{"study_id": 196727, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to quantify the effect of resveratrol supplementation on endothelial function by analyzing randomized controlled trials.", "results_summary": "Resveratrol significantly improved flow-mediated dilation (FMD) and reduced intracellular adhesion molecule-1 (ICAM-1) levels, but did not significantly affect VCAM-1, fibrinogen, or plasminogen activator inhibitor-1 (PAI-1). The findings suggest resveratrol may enhance endothelial function, particularly in cardiovascular disease patients.", "population_specificity": "Patients in randomized controlled trials (specific population not detailed beyond study inclusion criteria).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:41.916299+00:00"}
{"study_id": 196730, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize published studies assessing the effects of resveratrol supplementation on the complications of rheumatoid arthritis (RA).", "results_summary": "Resveratrol supplementation showed beneficial effects on RA complications by reducing inflammation and oxidative stress, modulating immune response, and down-regulating inflammatory gene expression. The review included 32 studies, suggesting promising therapeutic effects but highlighted the need for more human trials.", "population_specificity": "In vitro, animal, and human studies related to rheumatoid arthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.055189+00:00"}
{"study_id": 196728, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of SIRT1 in pre-eclampsia and assess whether resveratrol, a SIRT1 agonist, could mitigate vascular endothelial injury, placental dysfunction, and high blood pressure associated with the condition.", "results_summary": "Resveratrol was found to attenuate vascular endothelial injury and placental dysfunction, exerting protective effects by reducing blood pressure in pre-eclampsia-like conditions. SIRT1 deficiency in mice led to pre-eclampsia-like symptoms, which were reversed by resveratrol treatment.", "population_specificity": "Pre-eclampsia models (primarily in mice) and vascular endothelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.346131+00:00"}
{"study_id": 196732, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves hepatic and cardiovascular indices in patients with type 2 diabetes mellitus.", "results_summary": "The study found no significant difference between the resveratrol and placebo groups in hepatic steatosis or cardiovascular indices after 8 weeks of supplementation. The results suggest resveratrol had no measurable effect on these outcomes in the studied population.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM)", "effective_dosage": "1000 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.660490+00:00"}
{"study_id": 196731, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine if resveratrol supplementation could reduce hormonal migraine burden, disability, and improve quality of life in hormonal migraineurs.", "results_summary": "The study found no differences in the hormonal migraine burden index (HMBI) between resveratrol and placebo groups. Other outcomes (disability, quality of life) were not explicitly reported in the abstract.", "population_specificity": "62 hormonal migraineurs (mean age 37.5 \u00b1 0.8 years).", "effective_dosage": "75 mg twice daily.", "study_duration": "3 months per treatment arm (crossover design, total 6 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:43.049164+00:00"}
{"study_id": 196729, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the therapeutic effects and mechanisms of action of resveratrol in treating PCOS and its associated complications.", "results_summary": "Resveratrol supplementation showed potential in improving PCOS-related symptoms by reducing insulin resistance, dyslipidaemia, inflammation, oxidative stress, and regulating reproductive hormones, though further studies are needed for conclusive evidence.", "population_specificity": "Women with polycystic ovary syndrome (PCOS), including in vitro, animal, and human studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:43.133844+00:00"}
{"study_id": 196733, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the relationship between resveratrol and human microbiota, focusing on its potential applications in immune response, disease prevention, and new technologies like gene therapy.", "results_summary": "Resveratrol demonstrated beneficial effects on human microbiota, influencing genetic expression and microbial communities, with potential applications in inflammatory diseases, metabolic disorders, and bone regeneration. The studies included in vitro, in vivo, and ex vivo trials, showing consistent positive outcomes.", "population_specificity": "Human microbiota and associated conditions (e.g., inflammatory diseases, metabolic syndrome, degenerative diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:48.624971+00:00"}
{"study_id": 196734, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of resveratrol (RSV) on mild cognitive impairment (MCI) and Alzheimer's Disease (AD).", "results_summary": "The study found that RSV reduces amyloid-beta (A\u03b2) in AD patients and may improve cerebrovascular function, potentially lowering dementia risk. Results were based on a systematic review of five studies, with three focusing on AD and two on MCI.", "population_specificity": "Patients with mild cognitive impairment (MCI) and Alzheimer's Disease (AD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:49.511725+00:00"}
{"study_id": 196737, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of resveratrol supplementation, alone or combined with glucose and malate (RGM), on cognitive and functional performance in Alzheimer's disease (AD) patients.", "results_summary": "The study found that resveratrol, alone or as RGM, may delay cognitive impairment in AD patients, though human studies are still limited. It showed potential in influencing progressive cognitive and functional decline compared to placebo.", "population_specificity": "Patients with Alzheimer's disease (AD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:50.600145+00:00"}
{"study_id": 196736, "supplement_id": 1514, "safety_score": "100", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of resveratrol supplementation on glucose homeostasis, oxidative stress, inflammation, and microRNA expression in patients with type 2 diabetes on oral hypoglycemic drugs.", "results_summary": "Resveratrol supplementation significantly improved glycemic control, reduced insulin resistance, lowered oxidative stress and inflammation markers, and modulated microRNA expression compared to placebo, with no reported side effects.", "population_specificity": "Patients with type 2 diabetes mellitus on oral hypoglycemic drugs (n=94 completed the study).", "effective_dosage": "200 mg once daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:50.669181+00:00"}
{"study_id": 196735, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the biological properties and potential health benefits of \u03b5-viniferin, a resveratrol dimer, particularly its effects on inflammation, oxidative stress, and chronic diseases.", "results_summary": "The study found that \u03b5-viniferin exhibits strong anti-inflammatory and antioxidant properties, with potential benefits for managing chronic diseases such as cancer, obesity, vascular diseases, and neurodegeneration. However, bioavailability studies indicate poor absorption and high metabolism of the compound.", "population_specificity": "Not specified (in vitro and in vivo studies reviewed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:50.813871+00:00"}
{"study_id": 196739, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether resveratrol supplementation could reduce plasma levels of uremic toxins (IS, pCS, IAA) in nondialyzed CKD patients.", "results_summary": "Resveratrol supplementation did not reduce plasma levels of IS, pCS, or IAA in CKD patients. The study found correlations between IS and inflammatory markers but no significant effect from resveratrol.", "population_specificity": "Nondialyzed patients with chronic kidney disease (mean age 63 \u00b1 7.5 years, GFR 34 \u00b1 14 mL/min).", "effective_dosage": "500 mg trans-resveratrol per day (one capsule).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:52.614268+00:00"}
{"study_id": 196738, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to expand the potential applications of resveratrol and its acylated derivatives in functional supplements, cosmetics, and pharmaceuticals by modifying resveratrol with fatty acids of varying chain lengths.", "results_summary": "Resveratrol showed higher antioxidant efficacy than its acylated derivatives in DPPH, ABTS, FRAP, and ferrous chelation tests. Short-chain fatty acid mono- and di-substituted resveratrols, particularly monoacetate/diacetate, exhibited higher antioxidant efficacy in DPPH and ABTS assays, while medium-chain monoesters showed superior metal ion chelation ability.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:52.951781+00:00"}
{"study_id": 196740, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to classify studies on resveratrol's effects on cardiovascular biomarkers and identify protocol characteristics associated with different result profiles.", "results_summary": "The study grouped resveratrol interventions into three clusters based on biomarker responses, with higher doses (454.14 mg/day) reducing triglycerides and blood pressure, and lower doses (273.75 mg/day) increasing HDL over longer durations. Customizing resveratrol dose and duration could optimize its cardiovascular benefits.", "population_specificity": "Humans (specific baseline characteristics not detailed in the abstract).", "effective_dosage": "273.75 mg/day to 454.14 mg/day.", "study_duration": "74.21 days to 175.33 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:53.011402+00:00"}
{"study_id": 196741, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of oral resveratrol supplementation in type 2 diabetic patients, focusing on dose and duration.", "results_summary": "Resveratrol was superior to placebo in improving fasting blood glucose, total cholesterol, HbA1c, and systolic blood pressure, particularly at doses \u2265500mg. The meta-analysis included 17 RCTs with 871 patients, showing statistically significant benefits.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "\u2265500mg", "study_duration": "Three months (for HbA1c improvement)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:56.910660+00:00"}
{"study_id": 196742, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the role of resveratrol in lowering CRP and hs-CRP levels as markers of inflammation in various inflammatory disorders.", "results_summary": "Resveratrol supplementation significantly reduced both hs-CRP and CRP levels, with greater reductions observed in groups with \u226510 weeks of supplementation and at doses of \u2265500 mg/day for CRP.", "population_specificity": "Patients with various inflammatory disorders (specific conditions not detailed in the abstract).", "effective_dosage": "\u2265500 mg/day", "study_duration": "\u226510 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:58.010918+00:00"}
{"study_id": 196744, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the effects of Resveratrol on Sirt1 expression, focusing on both gene and protein levels.", "results_summary": "The study found that Resveratrol supplementation had beneficial effects on both SIRT1 gene and protein expression, based on a review of 12 selected articles.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:58.187880+00:00"}
{"study_id": 196745, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 30-day resveratrol supplementation affects components of the renin-angiotensin system (RAS), particularly ACE2, in adipose tissue and skeletal muscle in men with obesity.", "results_summary": "Resveratrol significantly reduced ACE2 (~40%) and leptin (~30%) in adipose tissue but did not affect other RAS components in adipose tissue or skeletal muscle. These findings suggest resveratrol may reduce SARS-CoV-2 viral entry potential in obese individuals.", "population_specificity": "Men with obesity", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:59.231539+00:00"}
{"study_id": 196743, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to evaluate the clinical significance of drug-food interactions of direct oral anticoagulants (DOACs), including potential interactions with food ingredients, dietary supplements, or herbs.", "results_summary": "The abstract does not provide specific findings related to Resveratrol, focusing instead on general interactions between DOACs and food or supplements.", "population_specificity": "Patients treated with anticoagulants (DOACs such as dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned (specific to Resveratrol)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:00.253483+00:00"}
{"study_id": 196749, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential benefits of resveratrol in cardiovascular diseases (CVD) and its possible role in mitigating COVID-19 severity in patients with cardiovascular complications.", "results_summary": "Resveratrol demonstrated cardioprotective, anti-hypertensive, vasodilatory, anti-diabetic, and lipid-improving effects. It also showed potential in regulating pathways involved in SARS-CoV-2 pathogenesis, such as immune stimulation and cytokine modulation.", "population_specificity": "Patients with cardiovascular diseases and potential COVID-19 complications (not explicitly specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:01.492686+00:00"}
{"study_id": 196748, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether resveratrol supplementation alone could stimulate sirtuins (particularly SIRT-1) to aid in treating excess weight and related comorbidities.", "results_summary": "Four of seven studies showed a significant increase in SIRT-1 levels with resveratrol supplementation, along with improvements in insulin sensitivity, lipid profile, metabolic flexibility, antioxidant capacity, energy expenditure, and reduced ectopic fat accumulation. However, the effect was not consistently confirmed across all studies.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Different dosages used (specific amounts not detailed in the abstract).", "study_duration": "Varying intervention times (specific durations not detailed in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:03.322458+00:00"}
{"study_id": 196747, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of resveratrol supplementation on cardiometabolic risk factors in patients with type 2 diabetes (T2D), metabolic syndrome (MetS), and nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Resveratrol showed minor benefits on some outcomes (e.g., blood pressure, lipid profile, HbA1c), but most effects were trivial, with low certainty of evidence. A clinically important effect was observed for HbA1c in the short term, but overall, evidence does not support resveratrol for managing cardiometabolic risk factors.", "population_specificity": "Patients with T2D, MetS, or NAFLD (1476 T2D, 727 MetS, 271 NAFLD participants).", "effective_dosage": "Not specified", "study_duration": "Varied; short-term (<12 weeks) for HbA1c analysis.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:03.457923+00:00"}
{"study_id": 196750, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the potential metabolic benefits of maternal resveratrol supplementation during pregnancy and lactation on offspring health, considering sex-specific responses and maternal diet influences.", "results_summary": "The study found inconclusive evidence regarding resveratrol's metabolic benefits for offspring, with noted differences in male and female responses and varying effects based on maternal diet.", "population_specificity": "Offspring of mothers with nutritional imbalances, overweight, or obesity (human and animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:04.802191+00:00"}
{"study_id": 196752, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review epidemiological and animal studies to assess resveratrol's potential as a reprogramming agent to prevent cardiovascular and kidney diseases of developmental origins.", "results_summary": "The review highlights resveratrol's positive influence on cardiovascular and kidney diseases, supported by animal studies, and outlines molecular mechanisms, but calls for further research before clinical translation.", "population_specificity": "Animal models and epidemiological human studies (developmental origins focus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:05.738726+00:00"}
{"study_id": 196751, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Resveratrol could improve exercise capacity in patients with mitochondrial myopathies by assessing changes in heart rate and peak oxygen utilization.", "results_summary": "The study was a randomized, double-blind, cross-over, placebo-controlled trial, but the abstract does not provide specific results regarding Resveratrol's effects on exercise capacity or mitochondrial function.", "population_specificity": "Eleven patients with genetically verified mitochondrial myopathies.", "effective_dosage": "1000 mg/day", "study_duration": "8 weeks per treatment phase, with a 4-week washout between phases.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:06.478142+00:00"}
{"study_id": 196753, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether resveratrol supplementation could reduce circulating sCD163 levels in patients with type 2 diabetes mellitus.", "results_summary": "The study found that resveratrol supplementation significantly reduced circulating sCD163 in T2DM patients, suggesting a potential role in mitigating macrophage activation linked to diabetes.", "population_specificity": "Patients with type 2 diabetes mellitus.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.044039+00:00"}
{"study_id": 196754, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of resveratrol supplementation on mRNA expression levels of PPAR\u03b1, p53, p21, p16, and serum levels of sCD163/sTWEAK ratio in patients with type 2 diabetes.", "results_summary": "Resveratrol significantly increased mRNA expression of p53 and p21 and reduced the sCD163/sTWEAK ratio, but had no significant effect on PPAR\u03b1 or p16 expression.", "population_specificity": "Patients with type 2 diabetes (n=71).", "effective_dosage": "1,000 mg trans-resveratrol daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.503195+00:00"}
{"study_id": 196755, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review evidence on the effects of Resveratrol on acute pancreatitis (AP) and explore its potential therapeutic mechanisms.", "results_summary": "Resveratrol was found to suppress oxidative stress and inflammation, directly impact cytokine generation, and attenuate AP and its complications through anti-inflammatory and antioxidant mechanisms. It shows promise as a future therapeutic component for AP treatment.", "population_specificity": "Not specified (review study, not a clinical trial)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:09.324840+00:00"}
{"study_id": 196756, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether resveratrol supplementation has an anti-obesity effect in the general population.", "results_summary": "The meta-analysis found no significant effect of resveratrol on weight loss or BMI, with only a small effect on waist circumference. Only three out of nineteen included studies showed any positive effect.", "population_specificity": "General population (human studies only, excluding observational and non-human studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:10.588626+00:00"}
{"study_id": 196757, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of resveratrol supplementation on diabetes-related parameters, including fasting blood glucose, insulin resistance, and glycated hemoglobin in humans.", "results_summary": "The meta-analysis found a significant reduction in insulin resistance with resveratrol supplementation. Approximately 60% of the included studies demonstrated at least one significant effect related to diabetes.", "population_specificity": "Humans with or at risk for diabetes (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:11.619334+00:00"}
{"study_id": 196758, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the antiviral properties of resveratrol, focusing on its mechanisms of action on cellular pathways involved in viral replication and virus-related diseases.", "results_summary": "The study highlights resveratrol's antiviral properties, demonstrating its ability to modulate inflammatory responses and inhibit viral replication in both in vitro and in vivo models. The review also discusses the current status of its clinical use.", "population_specificity": "In vitro mammalian cells and in vivo small animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:12.629554+00:00"}
{"study_id": 196759, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol supplementation could effectively treat non-alcoholic fatty liver disease (NAFLD) by reducing lipid accumulation and inflammatory markers.", "results_summary": "Resveratrol supplementation significantly reduced TNF-alpha and hs-CRP levels but showed no significant effect on other markers related to NAFLD management, including weight, liver enzymes, lipid profiles, and insulin resistance.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:13.698944+00:00"}
{"study_id": 196760, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Resveratrol (RSV) mimics the effects of caloric restriction (CR) in mice and its potential to counteract age- and obesity-related diseases.", "results_summary": "The study found inconsistent effects of RSV supplementation in mice, with some studies reporting modest improvements in insulin sensitivity and mitochondrial biogenesis, while others showed no significant reductions in body weight, glucose, or insulin levels. Human trials also reported controversial findings, suggesting RSV may only moderately mimic some aspects of CR under certain circumstances.", "population_specificity": "Mice and humans (based on literature review).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:15.173211+00:00"}
{"study_id": 196761, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a dietary supplement containing resveratrol precursors (GluReS) on redox status and inflammation in healthy humans compared to a glutathione-only supplement (GluS).", "results_summary": "The GluReS supplement significantly improved redox status by increasing reduced glutathione and other thiol species while decreasing oxidized species, and it also reduced neopterin levels (an inflammatory marker). The effects were more pronounced in the GluReS group compared to the glutathione-only group, with notable increases in vitamins C, E, and A.", "population_specificity": "Healthy human participants", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:17.091888+00:00"}
{"study_id": 196762, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to confirm whether low-dose resveratrol supplementation improves cerebrovascular function, cognitive performance, and insulin sensitivity in postmenopausal women over a longer-term period.", "results_summary": "Resveratrol significantly improved overall cognitive performance by 33%, enhanced cerebrovascular function (resting CBFV, CVR to hypercapnia, and cognitive stimuli), and improved insulin sensitivity markers. Women aged \u226565 showed additional benefits in verbal memory.", "population_specificity": "Postmenopausal women aged 45-85 years.", "effective_dosage": "75 mg trans-resveratrol twice daily.", "study_duration": "24 months (12 months per treatment arm in a crossover design).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:17.263285+00:00"}
{"study_id": 196763, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to confirm whether resveratrol supplementation could improve well-being, including pain perception, mood, menopausal symptoms, and quality of life in postmenopausal women, as suggested by a prior pilot study.", "results_summary": "Resveratrol supplementation significantly reduced composite pain scores, improved somatic menopausal symptoms and general well-being, and enhanced cerebrovascular responsiveness, particularly in overweight individuals. These benefits were sustained for at least 12 months.", "population_specificity": "125 healthy postmenopausal women", "effective_dosage": "75 mg twice daily (BID)", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:17.692028+00:00"}
{"study_id": 196764, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of resveratrol supplementation on liver enzyme levels in adults through a meta-analysis of randomized controlled trials.", "results_summary": "The pooled analysis showed no significant changes in liver enzyme levels (ALT, AST, ALP) with resveratrol supplementation. However, subgroup analysis suggested that dose, study duration, and population status might influence outcomes, indicating the need for further high-quality studies.", "population_specificity": "Adults (714 participants across 15 randomized trials)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:18.351728+00:00"}
{"study_id": 196766, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of 6-month resveratrol supplementation on metabolic health parameters, particularly insulin sensitivity, in overweight individuals.", "results_summary": "The study found no significant effect of resveratrol on insulin sensitivity, body composition, or other secondary outcomes, but did observe a reduction in HbA1c levels compared to placebo.", "population_specificity": "Overweight men and women (BMI: 27-35 kg/m\u00b2; aged 40-70 years)", "effective_dosage": "150 mg/d", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:20.746578+00:00"}
{"study_id": 196765, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the molecular mechanisms by which resveratrol may reverse or attenuate the progression of diabetic and non-diabetic cardiomyopathy caused by oxidative stress and other factors.", "results_summary": "Resveratrol was found to be a potent antioxidant capable of quenching excessive free radicals, potentially reversing or slowing cardiomyopathy progression. It also showed potential in protecting healthy hearts from oxidative stress-induced damage.", "population_specificity": "Diabetic and non-diabetic individuals with cardiomyopathy or at risk of oxidative stress-related heart damage.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:20.803335+00:00"}
{"study_id": 196767, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Resveratrol's potential in treating neurological disorders by inhibiting amyloidogenic pathways, promoting autophagy, and reducing tau protein aggregation.", "results_summary": "Resveratrol was found to inhibit amyloid-beta aggregation, stimulate autophagy, and reduce tau protein phosphorylation, suggesting therapeutic benefits for neurological disorders. The study highlights molecular pathways linking Resveratrol to these effects.", "population_specificity": "Not specified (general neurological disorder context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:21.820316+00:00"}
{"study_id": 196768, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of resveratrol as an adjunct to methylphenidate in the pharmacologic treatment of ADHD.", "results_summary": "Resveratrol improved ADHD symptoms according to parent-reported scales but not teacher-reported scales. The frequencies of complications were similar between treatment groups.", "population_specificity": "66 participants with ADHD", "effective_dosage": "500 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:22.313811+00:00"}
{"study_id": 196771, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of resveratrol supplementation on lipid profiles and liver enzymes in patients with metabolic syndrome (MetS) and related disorders.", "results_summary": "Resveratrol significantly reduced total cholesterol and increased GGT concentrations but had no significant effect on triglycerides, LDL-, HDL-cholesterol, ALT, or AST levels, suggesting potential cardio-protective benefits.", "population_specificity": "Patients with metabolic syndrome (MetS) and related disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:25.158540+00:00"}
{"study_id": 196769, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of resveratrol supplementation on CRP levels in patients with type 2 diabetes through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found a significant reduction in CRP levels in type 2 diabetes patients following resveratrol supplementation, with no significant publication bias. Subgroup analyses indicated that the effects were influenced by resveratrol dose and duration.", "population_specificity": "Patients with type 2 diabetes (491 subjects across six trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:26.299974+00:00"}
{"study_id": 196770, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol, as a Sirt1 activator, could mitigate vascular calcification (VC) by influencing endothelial function, cellular senescence, osteogenic transdifferentiation, and inflammatory responses.", "results_summary": "Resveratrol was found to retard VC by enhancing Sirt1 activity, which improves endothelial NO bioavailability, reduces oxidative stress, delays cell senescence, and suppresses osteogenic transdifferentiation and inflammation in vascular smooth muscle cells (VSMCs) and perivascular adipose tissue (PVAT).", "population_specificity": "Patients with chronic kidney disease (CKD) at risk of vascular calcification.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:26.638790+00:00"}
{"study_id": 196772, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of four weeks of resveratrol supplementation on muscle mitochondrial function, adipose tissue gene expression, systemic inflammation, and body composition in patients with COPD.", "results_summary": "Resveratrol did not improve muscle mitochondrial function, inflammatory markers, or systemic inflammation but increased markers of glycolysis and lipolysis in adipose tissue. Unexpectedly, it led to a reduction in lean body mass.", "population_specificity": "Patients with COPD (n=21, FEV not fully specified).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:27.771718+00:00"}
{"study_id": 196774, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of resveratrol supplementation on oxidative stress parameters through a systematic review and meta-analysis of clinical trials.", "results_summary": "Resveratrol supplementation significantly increased GPx serum levels but had no significant effect on SOD concentrations, MDA serum levels, or TAC compared to placebo. The study concluded that resveratrol may not have a clinically significant effect on oxidative stress.", "population_specificity": "Not specified (aggregate of 16 clinical trials)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:29.020832+00:00"}
{"study_id": 196773, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of resveratrol in reducing hyperglycemia and its antioxidant effects in patients with type 1 diabetes (T1D).", "results_summary": "Resveratrol supplementation for 60 days significantly decreased fasting blood sugar (FBS) and hemoglobin A1c (HbA1c), reduced oxidative stress markers, and increased total antioxidant capacity, but did not significantly affect insulin, HOMA-IR, HOMA-\u03b2, or markers of liver/kidney function and inflammation.", "population_specificity": "Thirteen patients with type 1 diabetes (T1D) of both sexes.", "effective_dosage": "500 mg capsules, twice daily.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:30.301190+00:00"}
{"study_id": 196775, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD).", "results_summary": "Resveratrol reduced fasting glucose levels in patients with T2DM and CHD after 4 weeks of supplementation. The study was a randomized, double-blind, placebo-controlled trial, indicating robust methodology.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) (n = 56).", "effective_dosage": "500 mg resveratrol per day.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:30.572529+00:00"}
{"study_id": 196776, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of micronized resveratrol on glycemic status, lipid profile, and body composition in overweight patients with type 2 diabetes mellitus (T2DM).", "results_summary": "Resveratrol supplementation significantly reduced fasting blood sugar and insulin levels while increasing high-density lipoprotein (HDL) cholesterol, but had no significant effect on anthropometric measures. The study concluded that resveratrol improved some cardio-metabolic parameters in T2DM patients.", "population_specificity": "Overweight patients with type 2 diabetes mellitus (BMI 25-30).", "effective_dosage": "1000 mg/day trans-resveratrol.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:32.481331+00:00"}
{"study_id": 196779, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of resveratrol supplementation on mRNA expression of PPAR\u03b1, p53, p21, and p16, as well as serum levels of CD163 and TWEAK, in patients with type 2 diabetes to assess its potential cardiovascular benefits.", "results_summary": "The abstract does not provide results, as the study is described as \"Pre-results.\"", "population_specificity": "Seventy-two subjects with type 2 diabetes.", "effective_dosage": "1000 mg/day trans-resveratrol.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:34.407101+00:00"}
{"study_id": 196778, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of resveratrol supplementation alongside non-surgical periodontal therapy on inflammatory, antioxidant, and periodontal markers in type 2 diabetes patients with periodontal disease.", "results_summary": "Resveratrol significantly reduced serum IL6 levels but showed no significant effects on TNF\u03b1, TAC, or CAL. The study suggests potential benefits for IL6 reduction but calls for further research.", "population_specificity": "43 patients with type 2 diabetes and chronic periodontitis.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:34.474703+00:00"}
{"study_id": 196780, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to summarize the effects of resveratrol supplementation on endothelial activation and blood pressures among patients with metabolic syndrome (MetS) and related disorders.", "results_summary": "Resveratrol significantly increased flow-mediated dilatation (FMD) levels but did not affect systolic or diastolic blood pressure (SBP and DBP). The findings suggest potential benefits for endothelial function without impacting blood pressure.", "population_specificity": "Patients with metabolic syndrome (MetS) and related disorders.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:35.061572+00:00"}
{"study_id": 196782, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the association between resveratrol supplementation and metabolic parameters in patients with metabolic syndrome.", "results_summary": "Resveratrol significantly improved glucose levels and waist circumference in humans, and reduced weight, triglycerides, systolic blood pressure, and increased HDL in animal models, but had no significant effect on total cholesterol.", "population_specificity": "Metabolic syndrome patients (human and animal models).", "effective_dosage": ">500 mg for significant effects in humans.", "study_duration": "\u226510 weeks for long-term interventions.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:35.678666+00:00"}
{"study_id": 196783, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether an EAA-based multi-ingredient nutritional supplement (including Resveratrol) could counteract age-related muscle mass, strength, and power loss and assess its impact on neuromuscular fatigue manifestations.", "results_summary": "The supplement significantly improved muscle mass, strength, power, and reduced visceral adipose tissue but did not affect myoelectric fatigue manifestations or task performance time.", "population_specificity": "38 healthy elderly subjects (8 male, 30 female; mean age 68.91\u00b14.60 years).", "effective_dosage": "Twice-daily consumption (specific Resveratrol dosage not detailed).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:37.681110+00:00"}
{"study_id": 196786, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize randomized controlled trials on the effects of resveratrol supplementation on body weight, BMI, waist circumference, and fat mass in adults.", "results_summary": "The pooled analysis of 28 trials showed a small but statistically significant reduction in body weight (WMD: -0.51 kg) with resveratrol supplementation, but no significant effects on BMI, waist circumference, or fat mass were reported.", "population_specificity": "Adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:38.434655+00:00"}
{"study_id": 196787, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize clinical trial results from the last decade on resveratrol's bioavailability, pharmacokinetics, and effects on various health conditions.", "results_summary": "The study found that resveratrol supplementation is safe, with its bioavailability influenced by dose, food matrix, and ingestion timing. It showed potential benefits for oxidative stress, inflammation, cardiovascular diseases, neurological diseases, and type 2 diabetes.", "population_specificity": "Humans with varying health statuses.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:38.517383+00:00"}
{"study_id": 196788, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize existing evidence and determine the effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress in patients with metabolic syndrome (MetS) and related disorders.", "results_summary": "Resveratrol supplementation significantly reduced C-reactive protein (CRP) and tumor necrosis factor-\u03b1 (TNF-\u03b1) concentrations but did not significantly affect interleukin 6 (IL-6) or superoxide dismutase (SOD) levels. The findings suggest a promising effect on certain inflammatory markers in MetS patients.", "population_specificity": "Patients with metabolic syndrome (MetS) and related disorders.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:41.777091+00:00"}
{"study_id": 196789, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to summarize the effect of resveratrol intake on weight loss through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis of 36 RCTs found that resveratrol supplementation significantly decreased body weight, with a standardized mean difference of -0.17 (95% CI: -0.33, -0.01).", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:42.455521+00:00"}
{"study_id": 196790, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of resveratrol in improving metabolic syndrome-related alterations and its interaction with gut microbiota.", "results_summary": "Resveratrol showed beneficial effects on metabolic syndrome in experimental animals, including improved glucose and lipid homeostasis, reduced fat mass, blood pressure, inflammation, and oxidative stress. Clinical trials remain inconclusive, but emerging data suggest its therapeutic potential may involve gut microbiota interactions.", "population_specificity": "Experimental animals and human clinical trials (specific population not detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:42.458560+00:00"}
{"study_id": 196791, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves lipid profiles in individuals with dyslipidemia.", "results_summary": "Resveratrol supplementation significantly reduced total cholesterol and triacylglycerol levels compared to placebo, but did not significantly affect HDL or LDL cholesterol levels.", "population_specificity": "Apparently healthy men and non-pregnant women aged 20-65 with newly diagnosed dyslipidemia.", "effective_dosage": "100 mg/d", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:42.462500+00:00"}
{"study_id": 196792, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore whether resveratrol could counteract diabetes by improving circulatory function and insulin sensitivity.", "results_summary": "The study suggests resveratrol may improve glucose uptake and vasodilator function, potentially alleviating insulin resistance by enhancing skeletal muscle blood perfusion. However, the role of circulatory improvements in insulin resistance has received limited attention.", "population_specificity": "Insulin-resistant individuals, particularly those with type-2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:43.639081+00:00"}
{"study_id": 196796, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves inflammatory markers in patients with type 2 diabetes.", "results_summary": "The study hypothesized that resveratrol could improve inflammatory markers in T2D patients, but the abstract does not provide specific results on efficacy or outcomes.", "population_specificity": "45 patients with type 2 diabetes", "effective_dosage": "800 mg/d", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:45.797333+00:00"}
{"study_id": 196793, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of resveratrol supplementation on inflammatory markers (IL-6, TNF-\u03b1, and hs-CRP) through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found significant reductions in TNF-\u03b1 and hs-CRP levels, supporting resveratrol's anti-inflammatory effects, though results for IL-6 were inconclusive. The study suggests resveratrol may be useful as an adjunct in managing metabolic diseases.", "population_specificity": "Adult participants aged 17 years and older (736 subjects across 17 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:47.138563+00:00"}
{"study_id": 196794, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of resveratrol on serum inflammatory mediators (CRP, IL-6, TNF-\u03b1) through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Resveratrol significantly reduced serum CRP levels but did not show a significant effect on IL-6 or TNF-\u03b1 concentrations. The study suggests further research is needed to confirm these findings across different populations.", "population_specificity": "658 adults aged 18-75 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:47.757705+00:00"}
{"study_id": 196798, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of resveratrol supplementation on cognitive performance and mood in healthy and clinical populations.", "results_summary": "Three studies found resveratrol improved some cognitive measures, two reported mixed results, and five found no effect. Pooled data showed significant improvements in delayed recognition and negative mood.", "population_specificity": "Healthy individuals and clinical populations (specific conditions not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:49.635329+00:00"}
{"study_id": 196797, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine if resveratrol enhances metabolic health and stimulates brown adipose tissue (BAT) in men at risk of developing type 2 diabetes (T2D).", "results_summary": "Resveratrol improved muscle mitochondrial function but did not enhance insulin sensitivity, lipid content, substrate utilization, energy metabolism, or BAT activity in men at risk of T2D.", "population_specificity": "Male first-degree relatives of patients with type 2 diabetes.", "effective_dosage": "150 mg/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:50.010652+00:00"}
{"study_id": 196799, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of chronic resveratrol supplementation on cognitive function in older adults.", "results_summary": "The study found that 1000 mg/day of resveratrol improved psychomotor speed (Trail Making Test part A) compared to lower doses and placebo, but no significant effects were observed in other cognitive domains.", "population_specificity": "Sedentary, overweight older adults (aged 65-93 years).", "effective_dosage": "300 mg/day and 1000 mg/day.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:50.247577+00:00"}
{"study_id": 196801, "supplement_id": 1514, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects and safety of resveratrol supplementation on liver fat content and cardiometabolic risk parameters in overweight, obese, and insulin-resistant subjects.", "results_summary": "Resveratrol supplementation did not significantly reduce liver fat content compared to placebo and showed no effects on cardiometabolic risk parameters. However, it was well tolerated and deemed safe.", "population_specificity": "Overweight, obese, and insulin-resistant subjects (N = 112).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:53.126524+00:00"}
{"study_id": 196802, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the effects of maternal resveratrol supplementation on metabolic health in offspring and explore its potential mechanisms.", "results_summary": "The abstract highlights resveratrol's beneficial properties, including antiobesogenic, antiatherosclerotic, and antidiabetic effects, but notes that its role in maternal intake and offspring metabolic health has not been extensively investigated. The study reviews existing evidence but does not present new experimental results.", "population_specificity": "Offspring of mothers with overweight, obesity, or gestational diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:54.361746+00:00"}
{"study_id": 196805, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether resveratrol supplementation affects oxidative stress markers in patients with type 2 diabetes.", "results_summary": "Resveratrol reduced plasma protein carbonyl content and intracellular superoxide anion levels in PBMCs, demonstrating an antioxidant effect in patients with type 2 diabetes.", "population_specificity": "48 patients with type 2 diabetes", "effective_dosage": "800 mg/day", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:54.498473+00:00"}
{"study_id": 196803, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether acute trans-resveratrol supplementation improves endothelial function in treated hypertensive patients with endothelial dysfunction.", "results_summary": "The study found that trans-resveratrol significantly improved endothelial function (measured by FMD) in women and patients with higher LDL cholesterol, but not in men or those with lower LDL cholesterol. No changes in blood pressure were observed.", "population_specificity": "Treated hypertensive patients (45-65 years old) with baseline endothelial dysfunction.", "effective_dosage": "Single dose of 300 mg trans-resveratrol.", "study_duration": "Acute intervention (effects measured 1.5 hours post-dose).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:56.803229+00:00"}
{"study_id": 196808, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of resveratrol on arterial stiffness (measured by CAVI) in patients with type 2 diabetes mellitus.", "results_summary": "Resveratrol supplementation significantly reduced systolic blood pressure, oxidative stress (d-ROMs), and arterial stiffness (CAVI), with modest reductions in body weight and BMI.", "population_specificity": "Patients with type 2 diabetes mellitus (n=50).", "effective_dosage": "100 mg resveratrol tablet (containing 27.97 mg oligo-stilbene) daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:58.369944+00:00"}
{"study_id": 196806, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of resveratrol supplementation on cognitive function, comparing it with other phytoestrogens, and assess its impact on cerebral vasodilator responsiveness.", "results_summary": "Resveratrol showed small-to-medium cognitive benefits in older adults and postmenopausal women, particularly in executive function and memory, linked to improved cerebral perfusion. No benefits were observed with red clover or grape formulations.", "population_specificity": "Postmenopausal women and older adults of mixed gender.", "effective_dosage": "150-200 mg daily", "study_duration": "At least 14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:58.642325+00:00"}
{"study_id": 196807, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to quantitatively evaluate the effects of resveratrol supplementation on risk factors of non-communicable diseases (NCDs) through a meta-analysis of randomized controlled trials.", "results_summary": "Resveratrol supplementation significantly reduced fasting glucose, total cholesterol, C-reactive protein, systolic and diastolic blood pressure in type 2 diabetes patients, and improved LDL-C, DBP, and HbA1c in trials lasting \u22653 months, but showed no significant effects on HDL-C, triglycerides, or insulin resistance.", "population_specificity": "1069 participants across 29 studies, including individuals with type 2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Varied, with notable effects in trials lasting \u22653 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:59.553575+00:00"}
{"study_id": 196810, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of resveratrol as a treatment for endometriosis by summarizing its effects in in-vitro and animal studies.", "results_summary": "Resveratrol reduced the number and volume of endometrial implants, suppressed proliferation, vascularization, inflammation, and cell survival while increasing apoptosis in animal models. In-vitro studies showed it reduced invasiveness and inflammatory responses in endometriotic stromal cells.", "population_specificity": "Animal models and in-vitro endometriotic stromal cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:01.201857+00:00"}
{"study_id": 196811, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether resveratrol supplementation could improve chronic pain and overall well-being in postmenopausal women, particularly in relation to age-related osteoarthritis.", "results_summary": "Resveratrol supplementation significantly reduced pain and improved total well-being compared to placebo, with these benefits correlating with enhanced cerebrovascular function.", "population_specificity": "80 healthy postmenopausal women", "effective_dosage": "75 mg, twice daily", "study_duration": "14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:01.223754+00:00"}
{"study_id": 196812, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to synthesize evidence from RCTs to evaluate the efficacy of resveratrol in managing non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The study found no significant benefits of resveratrol on liver enzymes (ALT, AST), weight, BMI, blood glucose, insulin, triglycerides, or LDL levels in NAFLD patients. The evidence was insufficient to support resveratrol's efficacy in managing NAFLD.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD) (n=158 across four RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:02.785341+00:00"}
{"study_id": 196816, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if chronic resveratrol supplementation could improve cerebrovascular function, cognition, and mood in post-menopausal women.", "results_summary": "The abstract does not provide specific results regarding the effects of resveratrol on cerebrovascular function, cognition, or mood.", "population_specificity": "Post-menopausal women aged 45-85 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:06.964576+00:00"}
{"study_id": 196814, "supplement_id": 1514, "safety_score": "70", "efficacy_score": 20, "quality_score": 85, "study_goal": "To investigate the effects of long-term resveratrol treatment on inflammation and metabolic syndrome in middle-aged men.", "results_summary": "Resveratrol treatment did not improve inflammatory status, glucose homeostasis, blood pressure, or hepatic lipid content. High-dose resveratrol (1000 mg) significantly increased total cholesterol, LDL cholesterol, and fructosamine levels compared with placebo.", "population_specificity": "Middle-aged men with metabolic syndrome (mean age 49.5 years, BMI 33.8 kg/m\u00b2).", "effective_dosage": "1000 mg (RSVhigh) or 150 mg daily.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:07.146993+00:00"}
{"study_id": 196813, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether resveratrol supplementation (at 40 mg/day and 500 mg/day) affects PTX3 concentrations and total antioxidant status (TAS) in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "Resveratrol supplementation increased PTX3 and TAS levels in a dose-dependent manner, with higher doses (500 mg/day) showing greater effects. Subgroup analyses identified factors like diabetes duration, aspirin use, and gender influencing PTX3 increments.", "population_specificity": "192 patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "40 mg/day and 500 mg/day.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:07.180201+00:00"}
{"study_id": 196815, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to clarify the role of resveratrol supplementation on adipokines by conducting a systematic review and meta-analysis of randomized placebo-controlled trials.", "results_summary": "The study found that the effects of resveratrol on adipokines were inconsistent across human clinical trials, indicating mixed results.", "population_specificity": "Not specified (general human clinical trial participants)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:07.267139+00:00"}
{"study_id": 196817, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of resveratrol and caloric restriction on Sirt1 serum concentrations and vascular biomarkers in healthy humans.", "results_summary": "Resveratrol significantly increased serum concentrations of Sirt1 but did not improve the lipid profile, unlike caloric restriction. Sirt1 mRNA expression remained unchanged after both interventions.", "population_specificity": "48 healthy participants (24 women) aged 55-65 years.", "effective_dosage": "500 mg/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:09.181208+00:00"}
{"study_id": 196818, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "To determine if resveratrol supplementation improves insulin sensitivity and metabolic health in patients with well-controlled type 2 diabetes.", "results_summary": "Resveratrol did not improve hepatic or peripheral insulin sensitivity but improved ex vivo mitochondrial function. A potential interaction with metformin was noted, possibly explaining the lack of insulin-sensitizing effects.", "population_specificity": "Seventeen subjects with well-controlled type 2 diabetes.", "effective_dosage": "150 mg/day (resVida)", "study_duration": "30 days", "interactions": "Possible interaction with metformin (correlation with dihydroresveratrol levels).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:10.514651+00:00"}
{"study_id": 196819, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if resveratrol supplementation combined with non-surgical periodontal treatment improves blood glucose, insulin resistance, triglyceride levels, and periodontal markers in type 2 diabetes patients with periodontal disease.", "results_summary": "Resveratrol significantly reduced fasting insulin, insulin resistance, and pocket depth compared to placebo, but did not significantly affect fasting blood glucose or triglyceride levels.", "population_specificity": "43 patients with type 2 diabetes and chronic periodontitis.", "effective_dosage": "480 mg/day (two pills).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:11.238396+00:00"}
{"study_id": 196800, "supplement_id": 1514, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether micellar solubilization improves the oral bioavailability of resveratrol from Vineatrol30 in humans.", "results_summary": "The study found that micellar supplementation increased the bioavailability of trans-resveratrol by 5.0-fold (AUC) and 10.6-fold (maximum plasma concentration) compared to native powder, but trans-\u03b5-viniferin was not detected in plasma or urine. The results were consistent with in vitro permeability tests.", "population_specificity": "Twelve healthy volunteers (six women, six men).", "effective_dosage": "Single dose of 500 mg Vineatrol30 (30 mg trans-resveratrol, 75 mg trans-\u03b5-viniferin).", "study_duration": "Single-dose intervention with 24-hour follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:13.300493+00:00"}
{"study_id": 196820, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether resveratrol could stimulate autophagy and restore oxidative balance in aged vasculature, potentially improving endothelial function in the elderly.", "results_summary": "The study suggests that resveratrol stimulates autophagy and may restore oxidative balance in the endothelium, indicating therapeutic potential for improving endothelial function in aging populations.", "population_specificity": "Elderly individuals with age-related endothelial dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:14.644443+00:00"}
{"study_id": 196823, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether resveratrol supplementation could improve disease activity, quality of life, and oxidative stress markers in patients with ulcerative colitis.", "results_summary": "Resveratrol significantly increased serum SOD and TAC levels, decreased MDA levels, improved disease activity, and enhanced quality of life in UC patients. The effects were statistically significant (p <0.001).", "population_specificity": "56 patients with active mild to moderate ulcerative colitis.", "effective_dosage": "500 mg/day resveratrol capsules.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:15.908831+00:00"}
{"study_id": 196821, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether resveratrol mimics caloric restriction and possesses life-prolonging properties in model organisms and humans.", "results_summary": "Resveratrol supplementation prolonged lifespan in approximately 60% of studies in model organisms, but results were inconsistent across species, with worms and killifish showing responsiveness while flies and mice largely did not. Factors like dose, gender, genetic background, and diet composition contributed to variability in effects.", "population_specificity": "Model organisms (yeast, flies, worms, rodents) and limited clinical studies in humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:16.512438+00:00"}
{"study_id": 196822, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of resveratrol supplementation on Nrf2 and NF-\u03baB expression in nondialyzed chronic kidney disease (CKD) patients.", "results_summary": "The study found no significant effect of resveratrol supplementation on Nrf2 or NF-\u03baB expression, nor any difference in proinflammatory or antioxidant biomarkers. The authors concluded that 500 mg of resveratrol for 4 weeks had no antioxidant or anti-inflammatory effect in this population.", "population_specificity": "Nondialyzed chronic kidney disease (CKD) patients (62.0 \u00b1 8.0 years old, 45% men, BMI 27.7 \u00b1 1.2 kg/m\u00b2).", "effective_dosage": "500 mg of resveratrol.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:17.421349+00:00"}
{"study_id": 196824, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of resveratrol in attenuating non-alcoholic fatty liver disease (NAFLD) through a meta-analysis of clinical trials.", "results_summary": "The meta-analysis found that resveratrol treatment led to small increases in low-density lipoprotein and total cholesterol levels but had negligible effects on other NAFLD features, suggesting minimal overall efficacy. The study concluded that more high-quality trials are needed to confirm these findings.", "population_specificity": "156 patients with NAFLD across four randomized, double-blinded, placebo-controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:18.306263+00:00"}
{"study_id": 196826, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent findings on the biological activities and multiple effects of resveratrol.", "results_summary": "Resveratrol exhibits cardiovascular protective, antiplatelet, antioxidant, anti-inflammatory, blood glucose-lowering, and anticancer activities, with studies conducted in animal and human models. The compound's wide range of benefits suggests a complex mode of action.", "population_specificity": "Animal and human models (in vitro and in vivo)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:18.988295+00:00"}
{"study_id": 196827, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether resveratrol could enhance cerebral vasodilator function and improve cognitive performance in adults with type 2 diabetes mellitus (T2DM).", "results_summary": "A single 75 mg dose of resveratrol significantly improved neurovascular coupling capacity and cognitive performance, particularly in multi-tasking tests, with effects correlating with plasma resveratrol levels. Higher doses (300 mg) also showed cognitive benefits, though the 75 mg dose was most effective for neurovascular coupling.", "population_specificity": "Adults aged 40-80 years with type 2 diabetes mellitus.", "effective_dosage": "Single doses of 0, 75, 150, and 300 mg administered at weekly intervals.", "study_duration": "Acute (single-dose) intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:23.030121+00:00"}
{"study_id": 196828, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of resveratrol supplementation on reducing body weight and modifying inflammatory markers in overweight and obese individuals.", "results_summary": "Most studies showed no significant change in body weight or fat distribution, but three out of four studies measuring inflammatory markers reported significant positive effects. The overall evidence was insufficient to support resveratrol for obesity management.", "population_specificity": "Overweight and obese individuals (mean age 49.2 \u00b1 8.3 years)", "effective_dosage": "75-3000 mg/day", "study_duration": "14-90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:23.164291+00:00"}
{"study_id": 196829, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the relevance of in vitro data for Resveratrol by comparing it with in vivo pharmacokinetic and pharmacodynamic data.", "results_summary": "The study highlights that in vitro activity of Resveratrol may not translate to achievable concentrations in vivo, questioning its relevance for human oral administration. No specific efficacy outcomes for Resveratrol are detailed in the abstract.", "population_specificity": "Not specified (general discussion of in vitro and in vivo data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:24.118294+00:00"}
{"study_id": 196830, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether resveratrol could mimic the vascular benefits of physical activity by activating sirtuin-1, AMPK, and estrogen receptor pathways.", "results_summary": "The study found that resveratrol acts as a partial mimetic of physical activity in animal and in vitro models but has weak support for beneficial effects in humans. It may even counteract the positive effects of physical activity, similar to other antioxidants.", "population_specificity": "Not specified (abstract discusses general human implications but does not detail study participants).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:24.617399+00:00"}
{"study_id": 196831, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether resveratrol supplementation could enhance mood, cognitive performance, and cerebrovascular function in postmenopausal women.", "results_summary": "The study found that resveratrol may improve cerebrovascular responsiveness to cognitive tasks and potentially enhance mood and cognition, suggesting a role in reducing dementia risk in postmenopausal women.", "population_specificity": "Healthy postmenopausal women", "effective_dosage": "75 mg twice daily", "study_duration": "14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:24.748000+00:00"}
{"study_id": 196832, "supplement_id": 1514, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if perinatal maternal resveratrol supplementation could prevent hypertension and improve vascular function in adult offspring of spontaneously hypertensive rats.", "results_summary": "Perinatal resveratrol supplementation prevented hypertension in adult offspring, improved nitric oxide bioavailability, and reduced bioconversion of big endothelin-1 to active endothelin-1, suggesting persistent vascular alterations. Growth restriction was observed in offspring by postnatal day 21 but resolved by 5 weeks of age.", "population_specificity": "Spontaneously hypertensive rat offspring (animal study).", "effective_dosage": "4 g/kg diet (maternal supplementation).", "study_duration": "From gestational day 0.5 until postnatal day 21.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:27.413742+00:00"}
{"study_id": 196833, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral trans-resveratrol supplementation increases choroidal thickness in young, healthy individuals.", "results_summary": "The study found a significant increase in foveal and extrafoveal choroidal thickness 1 hour after resveratrol administration, while no change was observed in the placebo group. The results suggest resveratrol may induce choroidal vessel vasodilation.", "population_specificity": "34 young, healthy participants (age- and gender-matched)", "effective_dosage": "Not specified", "study_duration": "Single administration (measured 1 hour post-treatment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:27.637851+00:00"}
{"study_id": 196825, "supplement_id": 1514, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether resveratrol supplementation at two dosages (500mg/day and 40mg/day) reduced CRP levels and improved metabolic parameters in T2DM patients.", "results_summary": "Resveratrol did not significantly reduce CRP concentrations or improve metabolic parameters in T2DM patients, though a dose-dependent (non-significant) CRP decrease was observed. Subgroup analyses suggested certain factors (e.g., shorter diabetes duration, younger age) were associated with greater CRP reduction.", "population_specificity": "192 patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "500mg/day and 40mg/day.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:30.265611+00:00"}
{"study_id": 196834, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine the efficacy of resveratrol supplementation on serum glucose and cardiovascular disease risk factors in individuals with schizophrenia.", "results_summary": "Resveratrol supplementation (200 mg/day) showed no significant changes in body weight, waist circumference, glucose, or total cholesterol. The placebo group exhibited worsened lipid profiles, while resveratrol may have prevented further lipid damage, though no significant differences were found.", "population_specificity": "19 men aged 18-65 with a diagnosis of schizophrenia.", "effective_dosage": "200 mg/day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:31.235101+00:00"}
{"study_id": 196837, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether chronic resveratrol consumption improves cognitive function, mood, and cerebral blood flow in healthy young adults compared to acute effects.", "results_summary": "Resveratrol showed limited cognitive benefits (improved accuracy in some tasks) and reduced subjective fatigue, with acute cerebral blood flow effects but no consistent cognitive improvements. It also increased diastolic blood pressure after 28 days.", "population_specificity": "Healthy adults aged 18-30 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:32.237504+00:00"}
{"study_id": 196835, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether trans-resveratrol could improve ultrafiltration in peritoneal dialysis patients by ameliorating angiogenesis-related markers.", "results_summary": "High-dose (450 mg/d) and low-dose (150 mg/d) trans-resveratrol significantly improved net ultrafiltration volume and rate compared to placebo. High-dose resveratrol also reduced angiogenesis markers (VEGF, Flk-1, Ang-2) and increased others (Tie-2, Tsp-1), while low-dose showed no significant effect on these markers.", "population_specificity": "Peritoneal dialysis patients experiencing ultrafiltration failure.", "effective_dosage": "150 mg/d (low-dose) or 450 mg/d (high-dose)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:32.646707+00:00"}
{"study_id": 196838, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and tolerability of resveratrol in overweight and obese adolescents with NAFL and assess its potential effects on hepatic steatosis and insulin sensitivity.", "results_summary": "The abstract describes the study protocol but does not report results, as it is a planned trial.", "population_specificity": "Overweight and obese adolescents (13 to <18 years) with non-alcoholic fatty liver (NAFL).", "effective_dosage": "75 mg twice daily (total 150 mg/day).", "study_duration": "30 days of intervention, with an additional 30 days of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:33.669463+00:00"}
{"study_id": 196836, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of 5-week resveratrol treatment on GLP-1 secretion, gastric emptying, and glycemic control in patients with diet-controlled type 2 diabetes.", "results_summary": "The study found that resveratrol supplementation had no significant effect on GLP-1 secretion, glycemic control, gastric emptying, body weight, or energy intake compared to placebo. The results did not support the use of resveratrol for improving glycemic control in this population.", "population_specificity": "Fourteen patients with diet-controlled type 2 diabetes (mean HbA1c: 6.4 \u00b1 0.2%).", "effective_dosage": "500 mg twice daily.", "study_duration": "5 weeks per intervention period, with a 5-week washout in between.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:34.037405+00:00"}
{"study_id": 196840, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of resveratrol supplementation on inflammation and quality of life in patients with active ulcerative colitis (UC).", "results_summary": "Resveratrol supplementation significantly reduced inflammatory markers (TNF-\u03b1, hs-CRP, NF-\u03baB activity) and improved quality of life and clinical colitis activity scores compared to placebo. No significant changes were observed in the placebo group.", "population_specificity": "50 patients with active mild to moderate ulcerative colitis.", "effective_dosage": "500 mg resveratrol capsule daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:36.487927+00:00"}
{"study_id": 196839, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the preclinical efficacy and safety of Resveratrol (RSV) as a therapeutic agent for osteoporosis using different rat models.", "results_summary": "RSV supplementation attenuated bone loss and structural deterioration in ovariectomized rats (postmenopausal osteoporosis model) and older rats (age-related and disuse osteoporosis models), but effects were inconsistent in younger rats. Safety was indicated by the absence of estrogen-sensitive tissue stimulation.", "population_specificity": "Ovariectomized rats (postmenopausal model), rats aged >6 months (age-related model), and hindlimb-suspended rats (disuse model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:36.764294+00:00"}
{"study_id": 196841, "supplement_id": 1514, "safety_score": "90", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review recent in vivo pharmacological effects of Resveratrol (2009-2014) and summarize clinical intervention studies, focusing on its potential benefits for aging, diabetes, and neurological dysfunction.", "results_summary": "The study found positive indications for Resveratrol in mammals, though discrepancies exist between animal and clinical studies due to varying doses, experimental settings, and subject variation. Clinical studies suggest potential benefits, but more definitive research is needed.", "population_specificity": "Mammals (animal studies) and human clinical trial participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:38.803503+00:00"}
{"study_id": 196843, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review pre-clinical and clinical studies examining the effects of resveratrol on obesity-induced negative health outcomes.", "results_summary": "Animal studies showed resveratrol improved mitochondrial function, glucose metabolism, body composition, and liver fat accumulation via SIRT1 activation, but human clinical trials confirming these benefits remain limited.", "population_specificity": "Rodents (pre-clinical) and humans (clinical, though limited).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:39.702290+00:00"}
{"study_id": 196842, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the latest advances in resveratrol's timing, dosage, formulation, bioavailability, toxicity, and drug interactions, as well as its effects on diseases like cancer, diabetes, neurodegeneration, and cardiovascular disease.", "results_summary": "The abstract notes that pre-clinical evidence suggests resveratrol may offer health benefits, but human studies show inconsistent results, with limitations such as small sample sizes and confounding variables. The review focuses on resveratrol's potential in combating various diseases but does not provide conclusive efficacy data.", "population_specificity": "Human studies (general, no specific subpopulation mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Resveratrol-drug interactions mentioned but not detailed", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:40.721744+00:00"}
{"study_id": 196845, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the in vivo evidence for Resveratrol's role in promoting bone health and reducing osteoporosis risk, as well as its potential mechanisms of action.", "results_summary": "Resveratrol supplementation showed protective effects on bone mass and trabecular bone in ovariectomized rodent models, attenuated bone loss in old rats under mechanical unloading, and increased longitudinal bone growth in growing rodents, though effects were inconsistent in mature rats.", "population_specificity": "Animal models (ovariectomized rodents, hindlimb unloaded rats, growing rodents)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:42.414163+00:00"}
{"study_id": 196846, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether resveratrol supplementation improves memory performance in older adults and to explore potential mechanisms underlying this effect.", "results_summary": "Resveratrol improved memory retention, increased hippocampal functional connectivity, reduced glycated hemoglobin (HbA1c) and body fat, and elevated leptin levels compared to placebo. These changes correlated with enhanced memory performance and better glucose metabolism.", "population_specificity": "Healthy overweight older adults (50-75 years, 18 females, total n = 46).", "effective_dosage": "200 mg/day", "study_duration": "26 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:42.646726+00:00"}
{"study_id": 196844, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of Resveratrol (RSV) on bone health in middle-aged obese men with metabolic syndrome (MetS), focusing on bone turnover markers, bone mineral density (BMD), and geometry.", "results_summary": "High-dose RSV (1,000 mg/day) significantly increased bone alkaline phosphatase (BAP) and lumbar spine trabecular volumetric bone mineral density (LS vBMD(trab)) in a dose-dependent manner, suggesting a positive effect on bone formation or mineralization. No consistent changes were observed in hip bone density.", "population_specificity": "Middle-aged obese men (mean age 49.3 \u00b1 6.3 years, mean BMI 33.7 \u00b1 3.6 kg/m\u00b2) with metabolic syndrome.", "effective_dosage": "1,000 mg/day (high dose) and 150 mg/day (low dose), orally administered.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:44.983995+00:00"}
{"study_id": 196847, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine the safety and metabolic outcomes of resveratrol supplementation in overweight, older adults.", "results_summary": "Resveratrol supplementation at 300mg/day and 1000mg/day was well tolerated, with no significant adverse effects and no differences in blood chemistry values compared to placebo. Glucose levels were significantly lower post-treatment in both resveratrol groups compared to placebo, though not significantly different from baseline levels.", "population_specificity": "Overweight, older adults (mean age 73\u00b17 years)", "effective_dosage": "300mg/day and 1000mg/day, orally ingested in capsule form twice daily", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:45.600900+00:00"}
{"study_id": 196848, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the in vivo effects of resveratrol treatment on various cancers (breast, colorectal, liver, pancreatic, and prostate) and assess factors influencing its efficacy.", "results_summary": "Resveratrol showed mixed outcomes in animal models, with positive, neutral, and negative effects depending on administration route, dose, tumor model, and species. Human and rodent evidence was inconsistent, highlighting variability in study conditions.", "population_specificity": "Animal models (species and strain not specified) and humans (limited data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:45.831641+00:00"}
{"study_id": 196849, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to describe resveratrol's role in modulating inflammation and oxidative stress and its potential benefits for patients with chronic kidney disease (CKD).", "results_summary": "Resveratrol shows promise in modulating inflammation and oxidative stress by activating Nrf2, increasing SIRT-1 expression, and reducing mTOR signaling, which may benefit CKD patients, but no clinical studies evaluating its effects in this population were identified.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:46.625981+00:00"}
{"study_id": 196851, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the lipid-modulating effects of resveratrol through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Resveratrol supplementation showed no significant effect on total cholesterol, LDL cholesterol, HDL cholesterol, or triglycerides, with results consistent across different doses, durations, and cardiovascular risk statuses. The study suggests that resveratrol's cardioprotective properties are not due to lipid modulation.", "population_specificity": "282 subjects (141 in each group) from seven randomized controlled trials, with varying cardiovascular risk statuses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:49.705115+00:00"}
{"study_id": 196852, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of 30-day resveratrol supplementation on adipose tissue morphology and underlying molecular processes in obese men.", "results_summary": "Resveratrol reduced adipocyte size, shifted adipocyte distribution toward smaller cells, downregulated Wnt and Notch signaling pathways, upregulated cell cycle regulation pathways, and enhanced autophagy-related lipid breakdown.", "population_specificity": "Eleven healthy obese men", "effective_dosage": "150 mg per day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:50.103307+00:00"}
{"study_id": 196853, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether resveratrol supplementation enhances training-induced improvements in cardiovascular health parameters in aged men.", "results_summary": "Resveratrol supplementation blunted the positive effects of exercise on cardiovascular health parameters, including maximal oxygen uptake, mean arterial pressure, lipid profiles, and prostacyclin levels, while not affecting Sirtuin 1 protein levels or the atherosclerosis marker VCAM-1.", "population_specificity": "27 healthy, physically inactive aged men (average age 65 years).", "effective_dosage": "250 mg trans-resveratrol daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:51.311278+00:00"}
{"study_id": 196854, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential cardioprotective and metabolic health benefits of resveratrol, including its effects on vascular health and obesity-related issues.", "results_summary": "The study found that resveratrol may improve cardiovascular and metabolic health, supported by preclinical evidence and initial human intervention studies. It suggests resveratrol could be a promising ingredient for reducing vascular and obesity-related risks.", "population_specificity": "Not specified (includes animal, in vitro, and human studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:53.472891+00:00"}
{"study_id": 196855, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of resveratrol as a preventive and therapeutic agent for metabolic diseases and obesity, focusing on its metabolic effects and mechanisms.", "results_summary": "Preclinical trials suggest resveratrol mimics calorie restriction effects via SIRT1 activation, improving glucose metabolism, reducing inflammation, and protecting against metabolic abnormalities in rodents. However, human clinical data remain scarce, and its therapeutic rationale is not well characterized.", "population_specificity": "Primitive species and rodents (preclinical); human data mentioned but limited.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:55.051268+00:00"}
{"study_id": 196856, "supplement_id": 1514, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "To evaluate the effects of chronic resveratrol supplementation on flow-mediated dilatation (FMD) and cognitive performance in obese adults.", "results_summary": "Chronic resveratrol supplementation for 6 weeks increased FMD by 23% compared to placebo, with a further 35% acute increase after a single dose. No effects were observed on blood pressure, arterial compliance, or cognitive performance.", "population_specificity": "Obese but otherwise healthy adults (BMI: 33.3 \u00b1 0.6 kg/m\u00b2).", "effective_dosage": "75 mg trans-resveratrol (Resvida) daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:55.115049+00:00"}
{"study_id": 196857, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effects of Longevinex\u00ae (L/RV), an oral resveratrol-based supplement, on retinal structure and function in patients with age-related macular degeneration (AMD).", "results_summary": "The study observed dramatic short-term anti-VEGF effects, including anatomic restoration of retinal structure and improved choroidal blood flow, with visual function improvements mirroring these changes. Effects lasted for one year or longer with daily use, though one patient eventually required anti-VEGF therapy.", "population_specificity": "Patients with AMD who progressed on AREDS II supplements, refused or failed anti-VEGF injections, or did not respond to conventional treatments.", "effective_dosage": "Not specified", "study_duration": "One year or longer", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:55.700912+00:00"}
{"study_id": 196858, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether resveratrol supplementation could mimic the metabolic and functional health benefits of calorie restriction by activating SIRT1 and improving energy utilization and insulin sensitivity.", "results_summary": "Resveratrol activates SIRT1, leading to metabolic improvements similar to calorie restriction, including enhanced energy utilization and insulin sensitivity. Current evidence supports resveratrol as a potential calorie restriction mimetic, though further studies on bioavailability and long-term efficacy are needed.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:58.209997+00:00"}
{"study_id": 196859, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the molecular changes in immune cells associated with long-term resveratrol intake and its anti-inflammatory effects in hypertensive male patients with type 2 diabetes.", "results_summary": "The study found that resveratrol supplementation reduced pro-inflammatory cytokines and altered inflammation-related microRNAs, but did not significantly affect metabolic markers beyond standard medication. A reduction in ALP and IL-6 levels was observed.", "population_specificity": "Hypertensive male patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "8 mg daily (as part of a grape extract).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:59.229299+00:00"}
{"study_id": 196860, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the potential therapeutic use of resveratrol in diabetes and diabetic pregnancy, focusing on its ability to prevent diabetic embryopathy.", "results_summary": "Resveratrol significantly improved embryonic outcomes by reducing developmental abnormalities in rodent models of diabetic embryopathy, likely due to its antioxidative, antidiabetic, and antidyslipidemic properties. However, its effects in human diabetic pregnancies remain unknown.", "population_specificity": "Rodent models of diabetic embryopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:59.509578+00:00"}
{"study_id": 196861, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether resveratrol supplementation could reduce markers of inflammation and oxidative stress in healthy adult smokers.", "results_summary": "Resveratrol significantly reduced C-reactive protein (CRP) and triglyceride concentrations while increasing Total Antioxidant Status (TAS). No significant changes were observed in uric acid, glucose, insulin, cholesterol, liver enzymes, weight, waist circumference, or blood pressure.", "population_specificity": "Healthy adult smokers", "effective_dosage": "500 mg resveratrol/day", "study_duration": "30 days per intervention phase (with 30-day wash-out periods)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:02.309576+00:00"}
{"study_id": 196862, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to examine the metabolic effects of high-dose resveratrol in obese human subjects, focusing on insulin sensitivity and other metabolic parameters.", "results_summary": "The study found that resveratrol supplementation had no significant effect on insulin sensitivity, glucose turnover, blood pressure, energy expenditure, lipid oxidation, fat content, or inflammatory and metabolic biomarkers in obese men. The results contrast with positive findings from animal and in vitro studies.", "population_specificity": "24 obese but otherwise healthy men", "effective_dosage": "High-dose (specific amount not stated)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:02.870875+00:00"}
{"study_id": 196864, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review newly discovered biological effects of Resveratrol, including its mechanisms of action and potential applications in cardiovascular and metabolic health.", "results_summary": "The study highlights Resveratrol's antioxidant, anti-inflammatory, and anticarcinogenic properties, along with potential benefits for metabolic and cardiovascular health and life expectancy. However, the exact mechanisms and optimal dosage remain unclear.", "population_specificity": "Not specified (general review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:03.321939+00:00"}
{"study_id": 196863, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the metabolic effects of resveratrol supplementation in nonobese, postmenopausal women with normal glucose tolerance.", "results_summary": "Resveratrol supplementation did not improve body composition, metabolic rate, plasma lipids, inflammatory markers, or insulin sensitivity in liver, muscle, or adipose tissue. It also did not affect its molecular targets (AMPK, SIRT1, NAMPT, PPARGC1A) in these tissues.", "population_specificity": "Nonobese, postmenopausal women with normal glucose tolerance.", "effective_dosage": "75 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:03.661737+00:00"}
{"study_id": 196866, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Resveratrol as a potential caloric restriction mimetic for promoting longevity and delaying age-related diseases.", "results_summary": "The study suggests Resveratrol is a promising alternative to caloric restriction, showing potential to delay aging and associated diseases by modulating stress responses and signaling pathways. However, specific efficacy data on Resveratrol are not detailed in the abstract.", "population_specificity": "Animals and humans (general, no specific subgroup mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:06.111832+00:00"}
{"study_id": 196850, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the beneficial effects of resveratrol supplementation on adipose tissue metabolism, particularly in comparison to exercise and thiazolidinediones.", "results_summary": "The study found that resveratrol supplementation had beneficial effects on adipose tissue metabolism, similar to exercise and insulin-sensitizing drugs, with a focus on mitochondrial and glyceroneogenic enzyme induction.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:07.267335+00:00"}
{"study_id": 196867, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral resveratrol supplementation improves glycemic control and associated risk factors in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "Resveratrol supplementation significantly improved hemoglobin A(1c), systolic blood pressure, total cholesterol, and total protein levels in T2DM patients, but no significant changes were observed in body weight or HDL/LDL cholesterol levels.", "population_specificity": "62 patients with type 2 diabetes mellitus from Government Headquarters Hospital, Ootacamund, India.", "effective_dosage": "250 mg/day", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:07.754129+00:00"}
{"study_id": 196868, "supplement_id": 1514, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential for drug-drug interactions involving resveratrol, particularly at high supplemental doses, by summarizing its effects on cytochrome P450 (CYP) isoenzymes.", "results_summary": "The study found that resveratrol may interact with various CYP enzymes, especially at high doses, potentially altering the metabolism of coadministered drugs. Intestinal interactions could also reduce first-pass metabolism, increasing systemic exposure to certain medications.", "population_specificity": "Healthy subjects and patients taking additional medications.", "effective_dosage": "1 g/day or above (high supplemental doses).", "study_duration": "Not specified.", "interactions": "Possible interactions with CYP substrates, particularly at high doses.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:08.524391+00:00"}
{"study_id": 196869, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to quantify the current knowledge of life extension from resveratrol using meta-analytic techniques.", "results_summary": "Resveratrol showed life-extending effects, most notably in yeast and nematodes, but results were inconsistent in higher-order species. Considerable heterogeneity between studies was observed, and few species conclusively demonstrated life extension.", "population_specificity": "Six species: yeast, nematodes, mice, fruitflies, Mexican fruitflies, and turquoise killifish.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:10.250513+00:00"}
{"study_id": 196871, "supplement_id": 1514, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether resveratrol supplementation mimics calorie restriction effects in obese humans by influencing metabolic rate, mitochondrial function, and lipid metabolism.", "results_summary": "Resveratrol reduced metabolic rate, improved mitochondrial respiration, lowered lipid content in the liver, decreased blood glucose and triglycerides, and improved markers of inflammation and blood pressure.", "population_specificity": "11 healthy, obese men", "effective_dosage": "150 mg/day (resVida)", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:10.930631+00:00"}
{"study_id": 196872, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review whether resveratrol, as a compound with calorie restriction-mimicking properties, could downregulate skeletal myocyte apoptotic signaling to combat sarcopenia.", "results_summary": "Preliminary data suggest that resveratrol may downregulate skeletal myocyte apoptotic signaling, potentially preserving muscle integrity and improving physical performance in late life, though further research is needed.", "population_specificity": "Aged individuals with sarcopenia or age-related muscle loss.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:11.210282+00:00"}
{"study_id": 196870, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize and discuss the neuroprotective effects of resveratrol on Alzheimer's disease (AD) and explore its potential mechanisms.", "results_summary": "Resveratrol exhibits neuroprotective benefits in animal models of AD by promoting non-amyloidogenic cleavage of amyloid precursor protein, enhancing amyloid beta-peptide clearance, and reducing neuronal damage. However, concerns like bioavailability, biotransformation, and potential pro-oxidant activities remain unresolved.", "population_specificity": "Animal models of Alzheimer's disease (specific human population not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:11.890133+00:00"}
{"study_id": 196873, "supplement_id": 1514, "safety_score": "80", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to examine the current state of knowledge on the effects of resveratrol on humans and develop guidelines for future clinical trials.", "results_summary": "The study found that resveratrol is generally well-tolerated but has poor bioavailability in humans. Few human studies have confirmed the physiological benefits observed in laboratory models, though many clinical trials are underway.", "population_specificity": "Humans (specific population not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:13.337526+00:00"}
{"study_id": 196874, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential role of resveratrol in aging and its protective effects, particularly in cardiovascular disease, as suggested by the \"French Paradox.\"", "results_summary": "The study implies a relationship between resveratrol and potential health benefits, including cardiovascular protection and aging, but notes a lack of clear-cut evidence for longevity.", "population_specificity": "Not specified (general dietary intake context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:14.838681+00:00"}
{"study_id": 196875, "supplement_id": 1514, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether resveratrol could mitigate oxidative stress and preserve seminal parameters during cryopreservation of human semen.", "results_summary": "Resveratrol prevented post-thawing lipoperoxidation in both fertile and infertile men but did not restore the decrease in sperm motility caused by cryopreservation. The effect was not dose-dependent.", "population_specificity": "Infertile and fertile men", "effective_dosage": "0.1, 1.0, and 10.0 mM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:16.159414+00:00"}
{"study_id": 36844, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the structural characteristics, physicochemical properties, gelling properties, and biological activities of Rhamnogalacturonan I extracted from Syzygium samarangense.", "results_summary": "The study found that Rhamnogalacturonan I exhibited excellent rheological and gelling properties, significant antioxidant activity, and immunomodulatory effects, including enhanced radical-scavenging abilities and cytokine production in RAW264.7 cells.", "population_specificity": "In vitro (RAW264.7 cell models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:16.364145+00:00"}
{"study_id": 36847, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of Rhamnogalacturonan I (RGL1) in abiotic stress responses and its interaction with proline and cell wall metabolism in Arabidopsis thaliana.", "results_summary": "The study found that RGL1 influences cell wall pectin composition and modulates root growth and vascular tissue development. Silencing RGL1 resulted in sensitivity to osmotic stress, and its expression was induced by stressors like mannitol, salt, hydrogen peroxide, and abscisic acid.", "population_specificity": "Arabidopsis thaliana (model plant)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:19.738164+00:00"}
{"study_id": 36845, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the impact of carrot-derived rhamnogalacturonan-I (cRG-I) on gut microbiota metabolite production, particularly indole-3-propionic acid (IPA), and its potential health benefits.", "results_summary": "cRG-I consistently increased IPA production (+45.8% at 1.5 g/d and +14.6% at 0.3 g/d) across all subjects, with a strong correlation to Bifidobacterium longum levels. It maintained high \u03b1-diversity, linked to elevated IPA production, and demonstrated benefits beyond short-chain fatty acids.", "population_specificity": "24 human adults", "effective_dosage": "1.5 g/d and 0.3 g/d", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:19.978795+00:00"}
{"study_id": 36846, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the extraction efficiency and compositional properties of Rhamnogalacturonan I (RG-I) from banana peel waste at different ripening stages and its potential applications.", "results_summary": "The study found that RG-I content varied with extraction conditions, with the highest RG-I content (111.1 mg/g AIS) obtained at 110\u00b0C for 5 minutes from ripening stage 7 peel, comparable to pectin with reported prebiotic ability. The results suggest potential applications in novel products, particularly as a gelling agent or prebiotic.", "population_specificity": "Banana peel waste at ripening stages 2, 5, and 7.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:20.352067+00:00"}
{"study_id": 36848, "supplement_id": 1515, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if a composite hydrogel based on rhamnogalacturonan I (RG) and fibrin could serve as a safe and effective delivery vehicle for the antitumor enzyme binase.", "results_summary": "The study confirmed the feasibility of creating biocompatible and biodegradable RG-fibrin hydrogels for prolonged binase release without compromising enzyme activity. The release time of binase could be regulated by adjusting fibrin and RG concentrations.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:20.459124+00:00"}
{"study_id": 36850, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of Rhamnogalacturonan I (RG-I) in cell-cell adhesion in poplar wood cell walls and its potential impact on biomass accessibility for biofuels.", "results_summary": "The study found that RG-I, along with xylan, plays a key role in cell-cell adhesion in poplar wood. Transgenic poplar lines expressing an RG-lyase showed enhanced cell separation, improved cellulose and xylan accessibility, and increased fragmentation under mechanical stress.", "population_specificity": "Hybrid poplar (Populus tremula \u00d7 P. alba cv. INRA 717-1B4) wood cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:23.882189+00:00"}
{"study_id": 36849, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect and potential mechanism of rhamnogalacturonan-I enriched pectin (GPS-1) from steamed ginseng on lipid metabolism in type 2 diabetes mellitus (T2DM) rats.", "results_summary": "GPS-1 alleviated hyperglycemia, hyperlipidemia, and hepatic lipid accumulation in T2DM rats, modulated gut microbiota composition, increased short-chain fatty acids, and activated the AMP-activated protein kinase pathway to regulate lipid metabolism.", "population_specificity": "Type 2 diabetes mellitus (T2DM) rat models induced by high-glucose/high-fat diet and streptozotocin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:24.212919+00:00"}
{"study_id": 36852, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-metastatic activities of polysaccharides in broccoli, particularly BCE-I (rich in galactose and arabinose), and its relevance to immune cell stimulation.", "results_summary": "BCE-I significantly enhanced immune cell activity (macrophages, NK cells) and inhibited lung metastasis of Colon26-M3.1 carcinoma cells in a dose-dependent manner, with partial dependence on NK cell function.", "population_specificity": "Murine (mice) models for immune response and lung metastasis.", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:24.679132+00:00"}
{"study_id": 36851, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare different extraction methods for RG-I pectin from sugar beet to optimize yield and purity.", "results_summary": "MAE with pH13 solvent yielded the highest RG-I (25.3%) and purity (260.2 mg/g AIS), while MAHE with water reduced extraction time to 10 minutes but had lower yield (7.5%) and purity (166.7 mg/g AIS). No significant differences were found between microwave and conventional heating when heating rate was controlled.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Extraction times varied (120 min for MAE/CSE, 10 min for MAHE)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:24.974859+00:00"}
{"study_id": 36854, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to isolate and characterize a rhamnogalacturonan-I (RG-I) pectic polysaccharide from pumpkin and investigate its binding affinity with lectins, particularly Galectin-3 (Gal-3), for potential functional food or drug applications.", "results_summary": "The study isolated a RG-I-like pectic polysaccharide (PPc) from pumpkin, identifying its structural composition and demonstrating its binding to Gal-3 with moderate affinity (1.26\u03bcM), suggesting potential as a Gal-3 inhibitor.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:29.139904+00:00"}
{"study_id": 36853, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Rhamnogalacturonan I (RGI)-rich pectins on cell migration and understand the underlying mechanisms.", "results_summary": "The study found that RGI-rich pectins, especially when combined with homogalacturonan (HG), inhibited cell migration more effectively than either alone. The effects were linked to altered cell morphology, reduced adhesion, and spreading, independent of galectin-3 (Gal-3).", "population_specificity": "L-929 cells (a mouse fibroblast cell line).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:29.270520+00:00"}
{"study_id": 36855, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Rhamnogalacturonan I (RG-I) as a potential colon-targeted drug delivery platform for treating conditions like inflammatory bowel disease and colonic cancer.", "results_summary": "RG-I microcapsules showed minimal release in simulated gastric and intestinal fluids but significantly higher release (9x) when exposed to RG-I cleaving enzymes, demonstrating targeted degradation by colonic microflora. The results suggest RG-I could serve as an effective colon-specific drug delivery system.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:30.020310+00:00"}
{"study_id": 36857, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to optimize the microwave-assisted alkaline extraction of galactan-rich Rhamnogalacturonan I (RG I) from potato pulp by-product and evaluate its functional properties.", "results_summary": "The study identified optimal extraction conditions (solid/liquid ratio, KOH concentration, microwave power, and time) for RG I, achieving a yield of 21.6% and productivity of 192.0 g/Lh. The functional properties of RG I-rich polysaccharides were comparable or superior to potato galactan and orange homogalacturonan.", "population_specificity": "Not specified (in vitro study on potato pulp by-product)", "effective_dosage": "Not applicable (extraction study)", "study_duration": "2.0 minutes (extraction time)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:33.348919+00:00"}
{"study_id": 36859, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the structural features of Rhamnogalacturonan I (RG-I-4) that contribute to its inhibitory effects on galectin-3, a protein linked to cancer progression.", "results_summary": "RG-I-4 effectively inhibited galectin-3-mediated processes, including hemagglutination, cancer cell adhesion, and T-cell binding. The study identified that galactan side chains were essential for activity, while arabinan side chains modulated activity based on their location, and the backbone played a critical role in maintaining structural conformation.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:34.121016+00:00"}
{"study_id": 36858, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize the physicochemical properties of flax fiber cell wall rhamnogalacturonan I (RG-I) and its fragments, focusing on its hydrodynamic behavior and spatial organization.", "results_summary": "The study found that RG-I retains its hydrodynamic volume despite a reduction in molecular weight, with DLS revealing three particle size ranges. NMR analysis indicated greater mobility in the backbone compared to side chains, suggesting a novel spatial organization where RG-I associates with the backbone at the periphery and side chains form a core zone.", "population_specificity": "Not specified (in vitro study on flax fiber cell wall components).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:34.235625+00:00"}
{"study_id": 36860, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare extraction methods (alkaline and enzymatic) for obtaining galactan-rich rhamnogalacturonan I (RG-I) from potato pulp by-product and analyze its structural properties.", "results_summary": "Alkaline extraction yielded higher RG-I (22-56%) with increasing concentration, while enzymatic extraction produced 38% yield but preserved more high-molecular-weight polysaccharides (>500 kDa; 62.2%). Harsh alkaline conditions debranched arabinan side chains more than galactan ones, and NMR confirmed the structure of galactan-rich RG-I.", "population_specificity": "Not applicable (in vitro study using potato pulp by-product)", "effective_dosage": "Not applicable (extraction methods compared, not human dosage)", "study_duration": "Not applicable (no intervention duration specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:35.349330+00:00"}
{"study_id": 36861, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of the MUM2/BGAL6 beta-D-galactosidase in the maturation of rhamnogalacturonan I in seed mucilage and its impact on mucilage swelling and extrusion.", "results_summary": "The study found that MUM2/BGAL6 beta-D-galactosidase is required for the maturation of rhamnogalacturonan I by removing galactose/galactan branches, which affects mucilage swelling and extrusion. Mutant mucilage showed altered polysaccharide allocation and increased branching between rhamnose and hexose residues.", "population_specificity": "Arabidopsis thaliana (Shahdara accession) seed coat epidermal cells", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:38.787234+00:00"}
{"study_id": 36862, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the subcellular localization and topology of rhamnogalacturonan I (RG-I) beta(1-->4)galactosyltransferase(s) in potato and its role in elongating beta(1-->4)-linked galactan on RG-I.", "results_summary": "The study found that beta(1-->4)GalT activity elongating beta(1-->4)-linked galactan on RG-I was located in the Golgi apparatus, with the catalytic site facing the lumen. The activity was membrane-integrated and resistant to proteinase unless Triton X-100 was present.", "population_specificity": "Potato (Solanum tuberosum L.) subcellular fractions (Golgi vesicles and soluble proteins).", "effective_dosage": "Not applicable (in vitro enzyme activity study).", "study_duration": "Not applicable (single experimental analysis).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:39.406490+00:00"}
{"study_id": 36856, "supplement_id": 1515, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the prebiotic properties of potato-derived Rhamnogalacturonan I (RG I) and its enzymatic hydrolysates, focusing on their effects on beneficial gut bacteria and short-chain fatty acid production.", "results_summary": "The study found that both RG I and its hydrolysates (oligo-RG I) selectively stimulated the growth of Bifidobacterium spp. and Lactobacillus spp., with oligo-RG I showing higher fermentation selectivity and greater short-chain fatty acid production compared to the parent RG I and fructooligosaccharides. No adverse effects on Bacteroidetes or Clostridium leptum populations were observed.", "population_specificity": "Immobilized fecal microbiota in a continuous culture system (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:39.675541+00:00"}
{"study_id": 36864, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to isolate and characterize the structure of Rhamnogalacturonan I (RG-I) from sugi (Cryptomeria japonica) and compare its arabinan sidechains to those of sycamore RG-I.", "results_summary": "The study identified RG-I's backbone as a disaccharide repeating unit of galacturonic acid and rhamnose, with arabinan and oligogalactosyl side chains attached to rhamnosyl residues. The arabinan sidechains of sugi RG-I differed structurally or in distribution from those of sycamore RG-I.", "population_specificity": "Xylem differentiating zones of sugi (Cryptomeria japonica D. Don, gymnosperm).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:42.899673+00:00"}
{"study_id": 36866, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to characterize additional pectic polysaccharides extracted from sycamore cell walls and compare their structural properties to known rhamnogalacturonan I.", "results_summary": "The study identified previously uncharacterized polysaccharides resembling rhamnogalacturonan I but with different degrees of branching, accounting for approximately 4% of the cell wall. These polysaccharides showed disparate ratios of 2- to 2,4-linked rhamnosyl residues compared to typical rhamnogalacturonan I.", "population_specificity": "Suspension-cultured sycamore (Acer pseudoplatanus) cell walls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:43.277887+00:00"}
{"study_id": 36865, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to elucidate additional structural features of Rhamnogalacturonan I (RG-I) isolated from sycamore cell walls, focusing on its arabinan and galactan side chains.", "results_summary": "The study identified that RG-I contains branched arabinan side chains attached to its backbone, which were largely removed by enzymatic treatment. The galactose-containing side chains were resistant to endo-galactanase but partially degraded by a combination of endo- and exo-galactanases, revealing an O-acetylated backbone structure.", "population_specificity": "Suspension-cultured sycamore cells (Acer pseudoplatanus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:43.715479+00:00"}
{"study_id": 196876, "supplement_id": 1515, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of carrot-derived rhamnogalacturonan-I (cRG-I) supplementation on gut microbiota composition and its potential protective role against viral respiratory infections.", "results_summary": "cRG-I supplementation increased the relative abundance of Bifidobacterium spp. and reduced gut microbiota heterogeneity, but respiratory symptom severity did not directly correlate with these changes. Certain Ruminococcaceae family members and microbiota richness were associated with a reduced post-infection response.", "population_specificity": "Healthy volunteers challenged with rhinovirus (RV16).", "effective_dosage": "Low-dose (0.3 g/day) and high-dose (1.5 g/day).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:44.202280+00:00"}
{"study_id": 196877, "supplement_id": 1515, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether dietary supplementation with carrot-derived rhamnogalacturonan-I (cRG-I) enhances immune responses and reduces symptom severity and duration in humans infected with rhinovirus-16 (RV16).", "results_summary": "The study found that cRG-I supplementation accelerated and augmented innate immune and anti-viral interferon responses to RV16 infection, improved NK cell function, and reduced symptom severity and duration while enhancing quality of life.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:48.112657+00:00"}
{"study_id": 36421, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a Rhodiola rosea phytosomal gel in enhancing wound healing by optimizing its formulation and assessing its dermal absorption and retention.", "results_summary": "The phytosomal gel demonstrated superior wound healing, achieving 98.16% wound reduction by day 14 in rats, outperforming both the R. rosea extract (95.17%) and standard treatment (97.13%). Histopathological analysis confirmed complete tissue regeneration and well-organized collagen fibers in the phytosomal gel group.", "population_specificity": "Wistar rats", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:48.470207+00:00"}
{"study_id": 196878, "supplement_id": 1515, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the effects of dietary supplementation with carrot-derived Rhamnogalacturonan I (cRG-I) on symptom severity, duration, and immune responses following rhinovirus infection in healthy individuals.", "results_summary": "cRG-I supplementation was safe, well-tolerated, and accelerated local immune responses to rhinovirus infection, with stronger effects at 1.5 g/day. At 0.3 g/day, it induced a faster interferon response and key anti-viral gene activity.", "population_specificity": "Healthy individuals aged 18-65 years.", "effective_dosage": "0.3 g/day and 1.5 g/day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:49.516330+00:00"}
{"study_id": 36863, "supplement_id": 1515, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the biosynthesis of 1,4-beta-galactan and its attachment to rhamnogalacturonan I in potato microsomal membranes.", "results_summary": "The study found that microsomal membranes synthesized 1,4-beta-galactan, primarily attached to rhamnogalacturonan I, with optimal activity at pH 6.0 and 7.5 mM Mn2+. The galactan was longer than a trimer and was effectively digested by specific enzymes, confirming its structure.", "population_specificity": "Suspension-cultured cells of potato (Solanum tuberosum L. var. AZY).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:51.220790+00:00"}
{"study_id": 36424, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Rhodiola Rosea (RHO) could protect the liver and kidneys from the negative effects of tilmicosin (TIL) by reducing oxidative stress and inflammation.", "results_summary": "Pre-administration of RHO inhibited TIL-induced increases in hepato-renal markers, decreased oxidative stress, and enhanced antioxidant activities in the liver and kidneys. RHO also reduced the expression of inflammatory genes (HSP70, NFkB, TNF-\u03b1 in the liver; desmin, nestin, vimentin in the kidneys) and improved histopathological changes caused by TIL.", "population_specificity": "Rats (animal study)", "effective_dosage": "Not specified", "study_duration": "12 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:53.710680+00:00"}
{"study_id": 36426, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review Rosavin's extraction, synthesis, pharmacological activities, and therapeutic potential for various chronic diseases.", "results_summary": "Rosavin demonstrated multiple biological activities, including antioxidant, lipid-lowering, analgesic, antiradiation, antitumor, and immunomodulation effects, with significant therapeutic potential for neurological, digestive, respiratory, and bone-related disorders.", "population_specificity": "Not specified (in vitro and in vivo studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:53.765190+00:00"}
{"study_id": 36422, "supplement_id": 1517, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Standardized Rhodiola rosea Injection (SRRI) on left ventricular remodeling and inflammatory mediators in patients with heart failure with reduced ejection fraction (HFrEF).", "results_summary": "SRRI significantly improved left ventricular remodeling (increased LVEF, reduced LVEDD and LVESD) and reduced inflammatory mediators (TNF-\u03b1, IL-6, hs-CRP) and biomarkers (BNP, NT-pro BNP) in HFrEF patients, with no significant increase in adverse reactions.", "population_specificity": "Patients with heart failure with reduced ejection fraction (HFrEF).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:54.532160+00:00"}
{"study_id": 36423, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Rhodiola rosea-derived exosome-like nanovesicles (RELNs) modified with DSPE-PEG2000-pYEEIE and loaded with Doxorubicin (DOX) for targeted melanoma inhibition.", "results_summary": "The pYEEIE-RELNs-DOX system showed better inhibition of A375 melanoma cell proliferation and improved tumor cell targeting compared to DOX alone or RELNs-DOX. The study suggests RELNs as a promising new drug delivery carrier for melanoma treatment.", "population_specificity": "In vitro study using melanoma cell line A375.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:55.545807+00:00"}
{"study_id": 36427, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether low-intensity pulsed ultrasound (LIPUS) combined with Rhodiola rosea could promote osteoblast proliferation and differentiation for bone repair.", "results_summary": "The study found that LIPUS combined with Rhodiola rosea strongly promoted osteoblast proliferation, reduced apoptosis, and increased OCN and ALO protein expression, suggesting enhanced bone formation.", "population_specificity": "Rat osteoblasts (OB) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:55.930339+00:00"}
{"study_id": 36429, "supplement_id": 1517, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Rhodiola Rosea rhizome on physiological activity and metabolic processes in rats fed a high-fat diet.", "results_summary": "Rhodiola Rosea reduced plasma triglycerides and bilirubin, increased alkaline phosphatase activity, and decreased urea concentration, but did not significantly alter organ mass or emotional status in rats.", "population_specificity": "24 laboratory rats consuming a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:57.593684+00:00"}
{"study_id": 36428, "supplement_id": 1517, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the beneficial effects of Rhodiola Rosea extract, its active components, and their potential use in treating chronic diseases.", "results_summary": "The study found that Rhodiola Rosea exhibits antioxidant, immunomodulatory, anti-aging, and anti-fatigue activities, with potential applications in treating diabetes, cancer, cardiovascular, and neurological disorders. It also highlights the need for future research on its mitochondrial effects.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:57.896375+00:00"}
{"study_id": 36430, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antiarthritic effects of Rhodiola Rosea extract (RSE) both as a monotherapy and in combination with low-dose methotrexate (MTX) in animal models of arthritis.", "results_summary": "The combination of RSE and MTX significantly reduced hind paw volume, increased body weight, and decreased inflammatory markers (IL-6, IL-17A, MMP-9, CRP) in the adjuvant arthritis (AA) model. RSE monotherapy showed significant antiarthritic effects in the collagen-induced arthritis (CIA) model but did not influence inflammatory markers in the AA model.", "population_specificity": "Animal models (collagen-induced arthritis and adjuvant arthritis).", "effective_dosage": "RSE (150 mg/kg body weight daily, orally); MTX (0.3 mg/kg body weight twice weekly, orally).", "study_duration": "Not specified in the abstract.", "interactions": "Positive interaction noted with methotrexate (MTX).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:02.107507+00:00"}
{"study_id": 36433, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to verify the relieving effect of total glycosides of Rhodiola rosea L. (RTG) on acute lung injury (ALI) in mice and clarify its mechanism.", "results_summary": "RTG significantly improved lung tissue pathology, reduced inflammatory cell infiltration, lowered proinflammatory cytokines (IL-6, IL-1\u03b2, TNF-\u03b1), and modulated oxidative stress markers (MPO, T-SOD, GSH, MDA). It also downregulated TLR4/NF-\u03baB pathway proteins, suggesting anti-inflammatory and antioxidant mechanisms.", "population_specificity": "LPS-induced ALI mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:03.130637+00:00"}
{"study_id": 36434, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Rhodiola rosea root extract on type 2 diabetes in a db/db mouse model, focusing on its potential to modulate gut microbiota and improve metabolic outcomes.", "results_summary": "Rhodiola rosea treatment improved fasting blood glucose levels, altered insulin response, reduced circulating lipopolysaccharide, and decreased hepatic C-reactive protein transcript levels, suggesting improved gut barrier integrity and reduced inflammation.", "population_specificity": "Leptin receptor knockout (db/db) mice, a model for type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:04.265735+00:00"}
{"study_id": 36431, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate Rhodiola rosea polysaccharides (RHPs) as an immunoactive drug delivery vector for hydrophobic drugs, focusing on tumor-targeting and macrophage modulation.", "results_summary": "The study found that RHPs modified with folic acid and stearic acid effectively encapsulated doxorubicin, demonstrated pH-sensitive release, enhanced tumor cell uptake, and modulated macrophage phenotypes (M0 to M1 and M2 to M1). The DOX@FA-RHPs-SA formulation showed superior antitumor effects compared to doxorubicin monotherapy by inducing apoptosis and immune modulation.", "population_specificity": "In vitro (tumor cells, RAW264.7 macrophages) and in vivo (animal tumor models) studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:04.487947+00:00"}
{"study_id": 36435, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Rhodiola rosea extract (RRE) WS\u00ae1375 on neuronal ROS regulation, bioenergetics, neurite outgrowth, and the BDNF pathway in stress-induced conditions.", "results_summary": "RRE increased bioenergetics, cell viability, and scavenged ROS, counteracting corticosteroid-induced dysregulation. It also promoted neurite outgrowth and increased BDNF levels, showing biphasic dose-response curves typical of adaptogenic extracts.", "population_specificity": "Human neuroblastoma SH-SY5Y and murine hippocampal HT22 cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:05.444310+00:00"}
{"study_id": 36432, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Rhodiola Rosea injection on cardiac function, ventricular remodeling, and the renin-angiotensin-aldosterone system (RASS) in rats with chronic heart failure.", "results_summary": "Rhodiola Rosea injection (6 mL/kg) improved cardiac function by reducing LVEDV and LVESV while increasing LVEF and LVFS. It also lowered plasma levels of miR-210-3p, miR-423-5p, miRNA-499, and BNP, and restored RASS indexes to normal levels in heart failure model rats.", "population_specificity": "Male Sprague-Dawley (SD) rats with induced chronic heart failure.", "effective_dosage": "6 mL/kg injected into the tail vein once daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:05.507848+00:00"}
{"study_id": 36437, "supplement_id": 1517, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Rhodiola Rosea injection on myocardial injury and delayed encephalopathy in patients with acute severe CO poisoning.", "results_summary": "Rhodiola Rosea significantly reduced hsCRP and ET-1 levels, increased VEGF, and improved cardiac function compared to the control group. It also showed potential benefits in reducing brain lesions detected via CT and MRI.", "population_specificity": "72 patients with acute severe CO poisoning, divided into control and observation groups.", "effective_dosage": "Large strain Rhodiola injection, once daily.", "study_duration": "Two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:06.837518+00:00"}
